Characterization of the Downstream Effects of the Rainbow Trout (Oncorhynchus mykiss) Chemokine, CK-2 on Macrophages by Tang, Cynthia
Characterization of the Downstream 
Effects of the Rainbow Trout 












presented to the University of Waterloo 
in fulfillment of the 
thesis requirement for the degree of 






Waterloo, Ontario, Canada, 2010 
 
 





I hereby declare that I am the sole author of this thesis. This is a true copy of the thesis, including any 
required final revisions, as accepted by my examiners. 





Chemokines are chemotactic cytokines that have the ability to attract leukocytes and guide 
them via a concentration gradient to sites of injury/infection. These small, basic proteins are 
secreted when induced and act on their target cells through G-protein coupled receptors. The 
downstream effects of this family of immune molecules are vast and have not fully been 
characterized. These versatile molecules seem to be able to serve as a link between the innate 
and adaptive immune systems as they are capable of inducing the inflammatory response of 
the innate immune system as well as triggering the initiation of the adaptive immune system. 
There are currently 46 known chemokines in humans. Chemokines have also been isolated 
from mouse, chicken, frog and fish.  
The rainbow trout chemokine CK-2 is the only known functional CC chemokine in 
possession of a mucin stalk. A previous study in this lab showed that stimulation by PHA 
causes a decrease in CK-2 transcript levels in rainbow trout head kidney and peripheral blood 
leukocytes (PBLs) as well as in the rainbow trout macrophage-like cell line RTS-11. CK-2 
protein was found expressed in RTS-11 but not in the spleen tissues of stimulated fish. A 
chemotaxis assay was performed to determine the activity of recombinant CK-2. It was 
observed that recombinant CK-2 induces the migration of rainbow trout PBLs as well as 
RTS-11 cells at an optimal concentration of 100ng/mL when purified under native 
conditions. The migration of cells treated with pertussis toxin is significantly reduced, 
indicating that it relies on G-protein coupled receptors. Treatment of RTS-11 cells with 
recombinant CK-2 results in changes in the expression profiles of various immune response 
genes including those that are involved in the inflammatory response and the responses 
against both intracellular and extracellular pathogens. Interestingly, rCK-2 induced an 
upregulation in the expression of the surface molecule CD4 at the level of transcription. The 
increase in CD4 may suggest a possible role for CD4 in the regulation of the cell‟s response 
to chemokines, indicating a potential function for the molecule in macrophages which has yet 
to be determined. This study shows that CK-2 is a functional chemokine that has a role in the 
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1.1 A General Overview of the Immune System 
The immune system is a complex network of cells, tissues and molecules that have evolved 
in order to defend multicellular organisms against pathogens and non-self entities. All 
organisms have innate immunity which confers non-specific defense against foreign 
invaders. The innate immune system is always present and therefore relatively quick to 
respond. It is the first line of defense against intruders and is able to trigger the adaptive 
immune system if the innate response is not sufficient. The adaptive immune system is only 
present in jawed vertebrates and can be highly diverse across species (Matsunaga and 
Rahman, 1998; Zapata et al., 2006; Rolff, 2007). It provides specific protection against 
pathogens and as the name suggests, can adapt to the characteristics of each. The adaptive 
immune system can recognize different types of invaders and mount the appropriate response 
to eliminate them. In contrast to the innate immune system, the adaptive response has the 
ability to develop memory of intruders that it comes in contact with which allows it to initiate 
a quicker and stronger response upon subsequent encounters (Murphy et al., 2007). 
Furthermore, the adaptive response is highly regulated by an army of molecules which 
organize, activate and deactivate immune cell behaviour. Most adaptive immune responses 
require multiple signals from cytokines, chemokines, receptors and ligands in order to be 
fully functional. These signals can come from the pathogens themselves or the innate 
immune response. Therefore the innate and adaptive immune systems are tightly integrated 
in their response to foreign intruders.  
1.2 Chemokines 
Chemokines are a family of chemotactic cytokines that are responsible for directing the 
migration of target cells to points of interest (Laing and Secombes, 2004a). Traditionally, 
these points of interest are sites of injury or infection (Laing and Secombes, 2004a). However 
more recently, evidence has been reported that chemokines also guide cells to their proper 
positions during development (Doitsidou et al., 2002; Molyneaux et al., 2003). The 
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intricacies of how these proteins work within the immune system is of great interest due to 
their role in intercellular communication. The network of immune cells depends on 
chemokines to relay messages of attack on the organism so that they can be effective in 
defending against disease. Therefore, the potential for the use of chemokines to assist in the 
treatment of many diseases may have a huge impact on medicine, both human and veterinary. 
It is for this reason that the downstream effects of individual chemokines should be 
investigated.  
The chemokine family is a group of basic, low-molecular weight proteins that range from 7 
to 14 kDa (Graves and Jiang, 1995). Structurally, they are characterized by three antiparallel 
β-strands, a C-terminal α-helix, and two essential disulfide bonds that are formed by four 
conserved cysteine residues. The positions of these essential cysteine residues are used to 
classify the members of the family into α, β, γ and δ subfamilies. For example, the α-
subfamily includes chemokines that have an amino acid residue sandwiched between the first 
two cysteine residues. Thus, they are also referred to as CXC chemokines. Chemokines in 
which cysteines one and two are adjacent to each other are designated as CC chemokines or 
as part of the β-subfamily. Gamma-chemokines are also known as XC chemokines because 
they lack cysteine one in addition to cysteine three and can only form one disulphide bond 
(Nomiyama et al., 2008). The fourth chemokine class is the CX3C or δ-subfamily and 
consists of one member, CX3CL1, commonly known as fractalkine (Bazan et al., 1997). This 
chemokine is distinctive due to the presence of its mucin stalk. A novel subfamily of 
chemokines has recently been proposed to classify four chemokines identified in zebrafish. 
These molecules are missing one of the first two cysteines while retaining cysteines three and 
four (Nomiyama et al., 2008). These new chemokines have been termed CX chemokines 
(Nomiyama et al., 2008). Although the current chemokine nomenclature reflects the 
classification system, a previous format identified the proteins as small inducible cytokines 
(SCY). Thus, the old system catalogued the CC, CXC, XC and CX3C chemokines as SCYA, 
SCYB, SCYC and SCYD, respectively (Zlotnik and Yoshie, 2000). 
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In addition to the cysteine classification system, chemokines can be organized into 
“inflammatory” and “homeostatic” classes (Zlotnik et al., 2006). Those that belong to the 
inflammatory class are only expressed when induced while homeostatic chemokines are 
expressed constitutively (Zlotnik et al., 2006). Chromosomal location of the genes encoding 
chemokines can also be used to categorize the molecular family (Zlotnik et al., 2006). 
Chemokines that are encoded on a chromosome with many others are known as “major-
cluster” chemokines, while those that appear with only one or two others are called “mini-
cluster” chemokines (Zlotnik et al., 2006). Chemokines that appear in unique locations are 
known as “non-cluster” chemokines (Zlotnik et al., 2006). 
1.3 Chemokine Families 
There are currently 46 known chemokines in humans, of which 17 are CXC, 26 are CC, 2 are 
XC and 1 is CX3C (Zlotnik et al., 2006). The first chemokine discovered and characterized 
was a CXC chemokine that is commonly referred to as interleukin-8 (IL-8) and officially as 
CXCL8 (Baggiolini et al., 1989; Zlotnik et al., 2006). CXCL8 is the prototypical CXC 
chemokine and apart from mammals, has been found in many species amongst birds, 
amphibians, and fish (Laing and Secombes, 2004a). This chemokine is known for being 
produced early in the inflammatory response and for a prolonged period of time (Remick, 
2005). It activates neutrophils as well as weakly stimulating monocytes and basophils 
(Graves and Jiang, 1995). CXCL8 is one of the CXC chemokines that includes the ELR 
motif, which confers specificity to neutrophils. Thus, CXC chemokines can be further 
subdivided into ELR+ and ELR- groups. The ELR+ chemokines in humans include CXCL1, 
CXCL2, CXCL3, CXCL5, CXCL6, CXCL7 and CXCL8 (Laing and Secombes, 2004a). 
These chemokines cause neutrophils to adhere to endothelial cells and to migrate towards 
sites of inflammation (Laing and Secombes, 2004a). CXC chemokines that do not possess 
the ELR motif are poor chemoattractants of neutrophils and instead attract lymphocytes and 
monocytes (Laing and Secombes, 2004a). Most CXC chemokines are found clustered on 
chromosome four, either in the GRO or the IP10 regions, but a few individual CXC 
chemokines are encoded singly on chromosomes five, 10, 17 and 19 (Zlotnik et al., 2006). In 
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addition, the majority of CXC chemokines belong to the inflammatory group, except for 
CXCL12 and CXCL13 which are homeostatic (Zlotnik et al., 2006). 
The chemokines of the CC subfamily target the mononuclear cells of the immune system and 
can be further classified based on activity into allergenic, pro-inflammatory, haemofiltrate 
CC chemokine (HCC), developmental, and homeostatic subgroups (Laing and Secombes, 
2004a). The HCC, allergenic, and pro-inflammatory chemokines are usually expressed when 
induced while the developmental and homeostatic chemokines are constitutively expressed 
(Laing and Secombes, 2004a). It should be noted that the inducible CC chemokines are 
clustered on chromosome 17 while the constitutive ones are scattered on chromosomes two, 
nine, 16 and 19 (Zlotnik et al., 2006; Laing and Secombes, 2004a). In addition, there are two 
allergenic chemokines, CCL24 and CCL26, which are found on chromosome seven (Zlotnik 
et al., 2006; Laing and Secombes, 2004a).  
However, not all CC chemokines are created equal in terms of gene structure and typical 
amino acid residue conservation. An interesting feature of the gene structure of both CCL14 
and CCL20 is that unlike most CC chemokines which are encoded by three exons and two 
introns, CCL14 and CCL20 are encoded by four exons and three introns (Pardigol, 1998; 
Nelson et al., 2001). Also of note is the evidence that CCL18 may have evolved from the 
fusion of two duplicates of the gene encoding CCL3 (Tasaki et al., 1999). It seems that there 
are mutated copies of this gene surrounding the locus and it has been proposed that this can 
possibly constitute a “hotspot” for the generation of new chemokine genes (Tasaki et al., 
1999). This may be of considerable importance since it may form the basis of how protein 
superfamilies, in particular the chemokine superfamily, expanded. In addition, there are some 
CC chemokines that, instead of having the usual four cysteine residues, have five or six and 
are therefore designated as C5 or C6-CC chemokines (Laing and Secombes, 2004b). The C5-
CC chemokines include CCL1 and CCL24 while CCL21 and CCL28 are C6-CC chemokines 
(Laing and Secombes, 2004b; Laing and Secombes, 2004a). These seemingly odd 
chemokines may provide answers to how chemokines evolve.  
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The XC subfamily has two known members in humans, XCL1 and XCL2 (Laing and 
Secombes, 2004a). XCL1 is commonly known as lymphotactin and is chemotactic for 
lymphocytes (Kelner et al., 1994). The gene encoding XCL1 is found on chromosome one in 
a mini-cluster with the gene for XCL2 (Kelner et al., 1994; Zlotnik et al., 2006). XCL2 was 
initially thought to be an allele of XCL1 because their nucleotide sequences have 97% 
identity (Yoshida et al., 1996). However, after additional analysis of the sequences encoding 
XCL1 and XCL2 it was decided that they were separate genes (Yoshida et al., 1996). It has 
been suggested that XCL1 evolved from a CC chemokine and was duplicated with an 
insertion in the first intron (Yoshida et al., 1996). It was then proposed that part of the first 
intron was deleted from one copy of the gene, resulting in XCL2 (Yoshida et al., 1996). 
Since the nucleotide sequences of XCL1 and XCL2 are so similar that the chemokines only 
differ by a single amino acid residue, the gene duplication must have occurred quite recently 
(Zlotnik et al., 2006). This provides further evidence that the expansion of the chemokine 
superfamily is driven by gene duplication events. 
The only known member of the CX3C subfamily in human is CX3CL1, also known as 
fractalkine (Bazan et al., 1997). This chemokine possesses a mucin stalk as well as a 
transmembrane domain and has been seen to exist in both anchored and soluble forms (Bazan 
et al., 1997). Soluble CX3CL1 is chemotactic for T-lymphocytes and monocytes while when 
expressed on endothelial cell surfaces, it aids in leukocyte adhesion (Bazan et al., 1997).  
1.4 Evolution of Chemokines 
Comparison of the mouse and human genomes show that immune system genes evolve more 
rapidly than any other and is probably due to high diversifying selection pressures (Zlotnik et 
al., 2006; Peatman and Liu, 2007). The mouse proteome includes homologs of most 
chemokines found in humans. The clustering of CXC and CC chemokines is similar in 
mouse and human with homologs even appearing in roughly the same order (Zlotnik et al., 
2006). Again, it is proposed that the clustering of chemokine genes is due to multiple tandem 
gene duplication events and the subsequent divergence of the gene copies (Zlotnik et al., 
2006). This is reflected in the low sequence identities of cluster homologs between species as 
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well as the promiscuity in receptor-ligand relationships (Zlotnik et al., 2006). The gene 
duplication probably occurred recently in evolutionary history due to the observation that in a 
phylogenetic tree of human and mouse chemokines, cluster chemokines form groups 
including chemokines from both species (Zlotnik et al., 2006). That is, the multitude of 
mouse and human cluster chemokines were probably derived from a few common ancestral 
genes that existed right before the divergence of the two species (Nomiyama et al., 2001). 
On the other hand, mini-cluster and non-cluster chemokines tend to be more conserved 
between species and have monogamous receptor-ligand relationships (Zlotnik et al., 2006). It 
is hypothesized that these chemokines maintain essential functions that constrain them from 
diverging too much (Zlotnik et al., 2006). Therefore mini- and non-cluster chemokines must 
reflect ancient, ancestral chemokines more closely than cluster chemokines (Nomiyama et 
al., 2001; Zlotnik et al., 2006). 
Fish represent an important period in evolution because they occur at the tipping point 
between invertebrates that have only an innate immune system and tetrapods that rely on 
adaptive immunity (Peatman and Liu, 2006). They include, in order of divergence, jawless 
fish (lamprey), cartilaginous fish (shark), ray-finned fish (zebrafish) and teleost fish (rainbow 
trout, cichlid) (Volff, 2005). Fish make for an interesting subject of study due to evidence of 
tetraploidization and rediploidization events (Volff, 2005). These events have resulted in 
multiple gene duplications which have a great role in the perpetration of molecular evolution 
(Volff, 2005). The first chemokine found in fish was a CC chemokine found in rainbow trout 
and named CK-1 (Dixon et al., 1998). CK-1 includes six cysteine residues, making it a 
member of the C6 group of CC chemokines (Dixon et al., 1998; Lally et al., 2003). The 
protein structure of CK-1 classifies it as a CC chemokine; however its gene organization is 
more akin to that of a CXC chemokine, having four exons and three introns (Dixon et al., 
1998). It has been suggested that the presence of traits from both CC and CXC subfamilies in 
CK-1 is indication that the rainbow trout chemokine is a modern version of the common 
ancestor of these subgroups (Dixon et al., 1998). As mentioned previously, the human CC 
chemokines CCL14 and CCL20 are also in possession of a four exon, three intron gene 
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structure. This could indicate that CCL14 and CCL20 are mammalian representatives of the 
ancestral chemokine. CK-1 shows 33-35% sequence identity to human CCL20 and shares a 
similar gene structure that is not common in CC chemokines (Lally et al., 2003). As well, in 
a phylogenetic tree constructed from known mammalian, chicken and fish CC chemokine 
sequences, CK-1 grouped with human and chicken CCL20 (Laing and Secombes, 2004b). 
Thus it is believed that CK-1 is most closely related to human CCL20 (Lally et al., 2003). 
A sequence encoding a CXCL8-like peptide was isolated from a stimulated rainbow trout 
leukocyte cDNA library (Laing et al., 2002). The amino acid sequence of the molecule has 
35%, 38% and 31% identity with human CXCL8, chicken cCAF, and lamprey CXCL8, 
respectively (Laing et al., 2002). Rainbow trout CXCL8 has an even higher identity with the 
flounder CXCL8, at 56%, which may reflect the closer temporal relationship trout shares 
with flounder than with lamprey (Laing et al., 2002). However, rainbow trout CXCL8 has a 
low sequence identity with CK-1, of 18% (Laing et al., 2002). The rainbow trout homolog 
lacks the ELR motif that is essential for human CXCL8 function, which appears to be 
characteristic of fish CXCL8-like chemokines (Laing et al., 2002). 
A second CC chemokine was identified in a cDNA library made from activated rainbow trout 
haematopoietic cells and named CK-2 (Liu et al., 2002). The protein shows 44% amino acid 
identity with a carp CC chemokine and about 20% identity with mammalian CC chemokines 
(Liu et al., 2002). An interesting feature of CK-2 is the presence of a glycosylated mucin 
stalk that is similar to the ones seen in the mammalian chemokines, CX3CL1 and CXCL16 
(Liu et al., 2002). CK-2 has 25% identity with CX3CL1 and is not similar to CXCL16 (Liu et 
al., 2002). The stalk in CK-2 is half the length of the CX3CL1 stalk and does not include a 
transmembrane domain (Liu et al., 2002). However, an allele of the CK-2 gene known as 
CK-2.1 includes a longer mucin stalk. It has been suggested that the mucin stalk was present 
in a common ancestor of modern chemokines, and then lost during the divergence of the 
protein since it is present in a rainbow trout CC chemokine, a mammalian CXC chemokine, 
and mammalian CX3C chemokines (Liu et al., 2002).  
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A search for chemokine-like sequences in rainbow trout ESTs yielded 15 CC chemokines, 
named CK-4 to CK-12, each having „a‟ and „b‟ forms (Laing and Secombes, 2004b). It is 
suggested that each „a‟ and „b‟ pair are closely related genes and that they may have even 
duplicated from each other (Laing and Secombes, 2004b). However it is also possible that the 
two sequences are alleles of the same gene (Laing and Secombes, 2004b). CK-5a and b have 
37-39% sequence identities to human CCL8 and chicken AH294 and incidentally, are 
grouped with these chemokines along with a Xenopus CCL5-like protein, in a phylogenetic 
tree constructed from known CC chemokines (Laing and Secombes, 2004b). The same tree 
grouped both CK-7a and b proteins with the human MCP subgroup, while CK-9 groups with 
human CCL25 as well as cichlid SCYA102 and SCYA103 (Laing and Secombes, 2004b). 
Trout CK-11 groups with zebrafish CCL1, cichlid SCYA101 and human CCL27 and CCL28 
(Laing and Secombes, 2004b). This new set of trout chemokines shows that extra cysteine 
residues have been conserved throughout the evolution of chemokines (Laing and Secombes, 
2004b). CK-7a and b have a fifth cysteine residue near their C-terminals and are most closely 
related to mammalian CCL1 and CCL24 which also have C-terminal cysteines (Laing and 
Secombes, 2004b). Likewise, both CK-10 and human CCL21 have fifth and sixth cysteine 
residues at their C-terminals (Laing and Secombes, 2004b). 
The lamprey is a jawless fish and is thought to be one of the earliest vertebrates, estimated to 
have appeared about 560 MYA (Najakshin et al., 1999; Laing and Secombes, 2004a; Volff, 
2005). Adaptive immunity was thought to be a “unique trait of jawed vertebrates” but it has 
recently been reported that the most ancient antibodies have been discovered to exist in 
lamprey (Rolff, 2007; Pancer and Mariuzza, 2008). Therefore, the lamprey makes for an 
interesting subject to study in an attempt to elucidate the evolution of the immune system.  
A CXCL8-like chemokine was identified from a cDNA library created from lamprey 
leukocytes and termed LFCA-1 (Najakshin et al., 1999). The protein shows 32% sequence 
identity to human CXCL8, 40% identity to the chicken homolog, cCAF and 41% identity to 
the dogfish version (Inoue et al., 2005; Najakshin et al., 1999; Laing and Secombes, 2004a; 
Inoue et al., 2003). However, LFCA-1 does not include the ELR motif responsible for the 
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ability of CXCL8 to recruit neutrophils (Najakshin et al., 1999). Again, the lack of an ELR 
motif in CXCL8-like molecules is common in fish. This indicates that ELR-directed 
neutrophil specificity probably evolved after the split between fish and amphibians. The 
lamprey homolog of CXCL8 is the most ancient known example of a chemokine (Najakshin 
et al., 1999). A phylogenetic analysis of LFCA-1 with mammalian and chicken chemokines 
showed that CXC chemokines form a monophyletic cluster and probably arose from a 
common ancestor (Najakshin et al., 1999).  
Invertebrate species have very primitive immune systems and lack the genes necessary to 
carry out adaptive immunity (Matsunaga and Rahman, 1998). However, because it is 
believed that all vertebrates possess the chemokine system, chemokines must have evolved 
before the divergence of vertebrates and invertebrates. It would therefore be interesting to 
determine which of the invertebrates that are more closely related to fish, encode chemokine-
like proteins in their genome. 
Although the sea squirt is an invertebrate, it does have a dorsal notochord and a primitive 
multiple organ system (DeVries et al., 2006). Since chemokines have an important role in 
cell migration during development, it is reasonable to predict that they would be present in 
sea squirt. However, a search of the draft genome of the sea squirt did not reveal any possible 
chemokine encoding sequences (DeVries et al., 2006). It is interesting that the sea squirt does 
not appear to possess the chemokine system because it is one of earliest organisms to possess 
a multiple organ system but does not have an adaptive immune system (DeVries et al., 2006). 
Therefore, one may infer that chemokines evolved for the function of directing leukocytes to 
sites of infection before acquiring the role of directing the migration of cells during 
development. 
Chemokines have been found in many organisms on the evolutionary timeline ranging from 
560 MYA (lamprey) to present (mammals). If chemokines exist in all vertebrates, then it 
stands to reason that chemokines also existed before vertebrates. However, chemokines have 
not yet been isolated from hagfish, a vertebrate species that diverged before lamprey. If they 
do exist in hagfish, the question of when chemokines appeared on the molecular scene 
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remains. Which invertebrate first started to produce a chemokine-like protein and what gene 
did it evolve from? These questions may start being answered as the genomes of more and 
more species are being sequenced. However the extinction of key species in the evolutionary 
path of the chemokine may prove to be an insurmountable challenge in the search for its 
origin 
Another glaring question asks if chemokines evolved to facilitate cell migration during the 
development of the multiple organ system and then later took on the role of reconnaissance 
to alert leukocytes to sites of infection? Or did the reverse happen? Zlotnik et al. suggests 
that the role of the CXCR4-CXCL12 pair in primordial germ cell homing in zebrafish is an 
indication that the chemokine system evolved in order to control cell movement (2006). 
However, chemokine-like molecules are curiously absent in the sea squirt, which has the 
need for chemotactic proteins to aid in the development of its multiple organ system. This 
seems to be evidence that chemokines evolved for the function of signaling leukocytes to 
migrate towards sites of infection before it was hijacked for its chemotactic abilities by 
development. 
Although the knowledge of non-mammalian chemokines is limited, recent studies have 
elucidated many novel chemokines, especially in fish species. The study of chemokines has 
been seen to be very important due to the extensive role played by the molecular superfamily 
in the progression and physiological responses to so many diseases. Thus, it is also important 
to determine the differences and similarities of the system between species in order to infer 
functions and responses from model organisms. Furthermore, understanding the evolution of 
chemokines will provide major insight on not only the immune system, but also development 
and physiology (Zlotnik et al., 2006). The search for putative chemokine-encoding genes in 
the zebrafish genome resulted in over a hundred sequences, indicating that gene expansion of 
the chemokine system occurred in fish species as well as mammalian. The sequencing of the 
genomes and ESTs of more species that diverged before mammals should result in the 
identification of many more chemokines. It has also been suggested that the localization of 
chemokine sequences can shed light on how the chemokine family emerged by looking at 
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possible gene duplications, translocations and divergence (Peatman and Liu, 2007). Through 
extensive comparisons of chemokine sequences and genome localization, we should then be 
able to decipher exactly how chemokines arose in vertebrates. As well, by looking at the 
functions of different classes of chemokines and deciphering the elements required for each 
specific function, we can determine how function-element relationships correlate across 
species. This can lead to the elucidation of how the chemokine sub-families evolved from 
each other. 
1.5 CK-2 
As discussed previously, the rainbow trout chemokine CK-2 is a CC chemokine with the 
interesting possession of a glycosylated mucin stalk. It has been shown by a Southern blot 
that there are at least two copies of the CK-2 gene in the trout genome (Liu et al., 2002). The 
mature protein consists of 163 amino acids with the mucin stalk comprising 88 amino acids, 
43 of which are potential O-linked glycosylation sites (Liu et al., 2002). Originally thought to 
be a novel chemokine, CK-2.1 has been determined to be an allele of CK-2 (Eshaque et al., 
unpublished). CK-2.1 has 98% nucleotide sequence identity with CK-2 and a longer mucin 
stalk (Eshaque et al., unpublished). Several putative CC chemokines that also include a 
potential glycosylated mucin stalk have been identified in zebrafish by searching within the 
zebrafish genome and EST databases (Nomiyama et al., 2008). However it has yet to be 
reported whether any of these chemokines are expressed and/or functional. It is interesting to 
note that mucin-stalk containing CC chemokines have only been found in fish to date and 
may possibly be unique to fish species. The function of the mucin stalk in chemokines has 
yet to be determined. 
CK-2 mRNA transcripts were seen in brain, head kidney, spleen and peripheral blood 
leukocytes (PBL) in phytohemaglutinin (PHA)-stimulated fish (Eshaque et al., unpublished). 
However CK-2 protein was only detected in head kidney, liver and brain tissues (Eshaque et 
al., unpublished). The rainbow trout spleen cell line RTS-11 expressed CK-2 at the protein 
level regardless of treatment with PHA (Eshaque et al., unpublished). Chemotaxis assays 
using recombinantly produced protein, showed that CK-2 is capable of inducing chemotaxis 
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in rainbow trout PBLs as well as RTS-11 (Eshaque et al., unpublished). The migration was 
blocked by the treatment of cells with pertussis toxin, anti-CK-2 antibody or excess CK-2, 
indicating that it was indeed the action of the chemokine (Eshaque et al., unpublished). 
1.6 Chemokine Signaling 
Chemokines produce their chemotactic effects by triggering intracellular signal transduction 
through pertussis toxin sensitive G-protein coupled receptors (GPCRs) (Kelvin et al., 1993). 
The relationship between chemokines and their receptors can be mutually promiscuous, with 
the ligands being capable of binding multiple receptors and vice versa (Peatman and Liu, 
2007). The chemokine receptor is part of the rhodopsin family of seven-transmembrane 
domain serpentine receptors (Kelvin et al., 1993). Chemokine receptors can usually be 
distinguished by the conserved DRYLAIV amino acid motif, found in the second 
intracellular loop (Murphy, 1994). Upon contact with its ligand, the receptor activates its 
associated G-protein such that it changes in conformation to release its βγ-subunit from the 
α-subunit (Bokoch, 1995). The released βγ-subunit is subsequently able to activate the 
effector protein phospholipase C (PLC), which proceeds to cleaving phosphoinositol 4,5-
bisphosphate (PIP2) into inositol triphosphate (IP3) and diacylglycerol (DAG) (Bokoch, 
1995). IP3 open IP3-gated calcium channels in the endoplasmic reticulum to release to the 
intracellular stores of Ca
2+
. The spike in intracellular Ca
2+
 can then trigger many signaling 
pathways. It can cause DAG to activate protein kinase C (PKC), which goes on to 
phosphorylate a variety of proteins involved in leukocyte activation (Bokoch, 1995). On the 
other hand, the α-subunit can activate Src tyrosine kinases which proceed to activate the 
MAP kinase signaling cascade, resulting in gene transcription (Soldevila and Garcia-Zepeda, 
2007). Src can also activate PI3 kinase which helps initiate the molecular events that lead to 
chemotaxis (Soldevila and Garcia-Zepeda, 2007). 
In addition, chemokine receptors are capable of mediating their effects through the 
JAK/STAT signaling pathway (Vila-Coro et al., 1999). The ligand-bound receptor dimerizes 
causing the recruitment and activation of Jak, which facilitates phosphorylation of the 
receptor (Soldevila and Garcia-Zepeda, 2007). This allows for Stat to be engaged and 
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activated so that it can translocate to the nucleus and induce gene transcription (Soldevila and 
Garcia-Zepeda, 2007).  
Although we know many of the physiological effects that chemokines have on immune 
system cells, there is little comprehensive information on how these molecules affect the 
overall immune-related gene expression that perpetrates these end results. There have been 
few studies over the past twenty years on how chemokines affect the gene expression profiles 
of the cells that they act on. Jiang et al., showed that the CC chemokine MCP-1, or CCL2, 
can regulate the expression of adhesion molecules as well as cytokines in human monocytes 
(Jiang et al., 1992). It was seen in this study that CCL2 induces interleukin (IL)-1 and IL-6 
while having no effect on tumour necrosis factor-alpha (TNFα) (Jiang et al., 1992). It was 
proposed on the basis of this study that CCL2 modulates the chemotaxis of monocytes 
through the regulation of adhesion molecules and that its effect on the inflammatory 
cytokines points to a role in inflammation (Jiang et al., 1992). It was reported by Taub et al., 
that incubation of activated type 1 and type 2 helper T-cells with various CC chemokines 
induced IL-2 production and proliferation of clones (Taub et al., 1996). However, a study on 
the effects of CC chemokines on CD4
+
 helper T-cells showed that MIP-1α, or CCL3, does 
not cause an increase in IL-2 in naive T-cells but instead induces the expression of interferon 
(IFN) 2, also known as IFNγ, resulting in type 1 helper T-cell activation (Karpus et al., 
1997). In addition, this group saw that CCL2 exposure of these cells caused an increase in 
IL-4 production indicating a push towards type 2 immune T-cell response (Karpus et al., 
1997). In addition, a study by Gu et al., reported that CCL2 induces IL-4 production in mice, 
giving further indication that it is responsible for directing a TH2 immune response (Gu et al., 
2000). The gene expression profile of monocytes exposed to CCL5 was investigated by an 
Italian research group (Locati et al., 2002). They reported that CCL5 does not induce TNFα 
or IL-6 and only stimulates IL-1β at the mRNA transcript level (Locati et al., 2002). On the 
other hand, it was seen in this study that CCL5 induced the production of genes that affect 
the extracellular matrix and may be the mediators of CCL5-driven chemotaxis (Locati et al., 
2002). It was seen in a study on cultured rainbow trout monocytes the rainbow trout version 
of CXC chemokine IL-8, or CXCL8, invokes the expression of pro-inflammatory cytokines 
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IL-1β and TNFα (Montero et al., 2008). In addition, IL-8 can induce a positive-feedback loop 
in which it stimulates its own expression (Montero et al., 2008). Conversely, the rainbow 
trout CC chemokine CK-6 does not induce the expression of pro-inflammatory genes but 
does increase expression levels of iNOS and integrin molecule CD-18 (Montero et al., 2008). 
The induction of iNOS possibly indicates that CK-6 has a role in the activation of 
macrophages while the increased expression of CD-18 could be responsible for its 
chemotactic effect (Montero et al., 2008). These studies show that not only do chemokines 
have an effect on gene expression; they also use their ability to regulate gene expression to 
mediate their effects on leukocytes. In light of this, we can use the gene expression profiles 
of immune system cells to determine chemokines functions other than the induction of 
chemotaxis. 
1.7 Research Objective 
The objective of this research was to elucidate the downstream effects that CK-2 has on the 
immune system. Specifically, the endeavour was to determine how CK-2 affects the 
expression of immune-related genes using the macrophage and monocyte-like cells of the 
rainbow trout spleen cell line, RTS-11. Recombinant CK-2 was produced and purified under 
native conditions then tested for functional capability by testing its chemotactic capacity 
towards RTS-11 and peripheral blood leukocytes isolated from rainbow trout. The active 
protein was then used to treat RTS-11 in time course and dose response experiments. RNA 
was collected from each time point and dose response sample and converted to cDNA in 
order to analyze how various immune-related genes were affected by rCK-2. The expression 
data was subsequently used to assemble a gene expression profile which may be able to 
afford us the ability of predicting the immune response that would occur upon the induction 
of CK-2 by different types of pathogens. Knowing the types of infection that CK-2 is able to 
stimulate an immune response against can assist in the design of vaccines towards these 




Materials and Methods 
2.1 Expression, Purification, and Analysis of Recombinant Protein 
2.1.1 Pilot Expression of Recombinant CK-2 
The full-length cDNA sequence of rainbow trout chemokine CK-2 was cloned into the 
pRSET A vector (Invitrogen, CA, USA) by a previous student. This vector was used to 
transform competent BL21(DE3)pLysS Escherichia coli cells (Novagen, WI, USA) 
according to the pRSET A, B, C transformation protocol detailed in the technical manual 
provided by Invitrogen. The transformed bacteria were plated on SOB plates containing 
50μg/mL of ampicillin (Sigma, MO, USA) and 35μg/mL of chloramphenicol (Sigma, MO, 
USA) and grown at 37°C. A colony was used to inoculate 2mL SOB including ampicillin 
and chloramphenicol and incubated in a 37°C shaking water bath overnight. The culture was 
used to make a glycerol stock, by adding 200µL of sterile 50% glycerol to 800µL of culture, 
and then stored at -80°C. A loopful of the glycerol stock was used to inoculate 2mL 
overnight cultures with antibiotics. A volume of 750µL of the 2mL overnight culture was 
used to inoculate a 25mL overnight culture with antibiotics. The 25mL culture was incubated 
in a 37°C shaking water bath until it reached an OD600 of 0.52, then induced with isopropyl 
β-D-1 thiogalactopyranoside (IPTG) (Fermentas, ON, Canada) to a final concentration of 
1mM. Starting at time zero, 1mL samples were taken at each hour for an additional eight 
hours. Samples were then taken every three hours until the culture had been grown for 24 
hours. All samples were centrifuged at 15000rpm in a benchtop microcentrifuge for 5mins 
immediately after being taken. The supernantants were discarded and the pellets were stored 
at -20°C. 
2.1.2 Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
Analysis 
The pilot expression study samples were thawed on ice and run on a sodium dodecyl sulfate 
(SDS) polyacrylamide gel for protein analysis. Samples were diluted 1:2 with sample buffer 
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(24mM Tris-HCl, 10% glycerol, 0.8% SDS (Fisher Scientific, ON, Canada), 5.76mM β-
mercaptoethanol (Sigma, MO, USA), 0.04% bromophenol blue). The 12% resolving gel with 
1.5M Tris-HCl (pH 8.8), 30% Acrylamide/Bis-acrylamide 37.5:1 solution (Bioshop, ON, 
Canada), 10% SDS (Fisher Scientific, ON, Canada), 10% ammonium persulphate, and 
TEMED (Biorad, CA, USA). The 4% separating gel was made with all the same ingredients 
except for 1.5M Tris-HCl (pH 8.8), which was substituted with 0.5M Tris-HCl (pH 6.8). The 
gels were cast and run using the Mini-Protein® II gel aparatus (Bio-Rad, CA, USA). 
Samples were run through the separating gel at 76V until they passed into the resolving gel 
and then run at 170V. Gels were stained in a 0.1% Coomassie blue G-250 (MP Biomedicals, 
OH, USA) staining solution and destained in a solution containing 5% methanol and 7.5% 
acetic acid. 
2.1.3 Bulk Expression of Recombinant CK-2 
A loopful of the CK-2 glycerol stock was used to inoculate 2mL overnight cultures with 
antibiotics. A 50mL overnight culture with antibiotics was inoculated with 100µL of the 2mL 
overnight culture. From the 50mL overnight culture, 24mL was pelleted, resuspended in 
fresh SOB media, and subsequently used to inoculate 300mL of SOB in a 1L Erlenmyer 
flask. The 300mL culture was incubated in a 37°C shaking water bath until it reached an 
OD600 of 0.4-0.6. Cultures were induced to make recombinant CK-2 by IPTG to a final 
concentration of 0.1mM, then allowed to grow for an additional five hours, as determined by 
the pilot study to be the optimal growth time (Section 2.1.2). Cultures were harvested by 
pelleting bacterial cells at 10,000rpm for fifteen minutes in a Sorvall floor model centrifuge 
with an SLA-1500 rotor (Thermo Scientific, MA, USA). Cell pellets were stored at -80°C 
until pellets from at least 8 cultures were collected. 
2.1.4 Optimization of Recombinant Protein Production 
In order to optimize aeration conditions for rCK-2 production, 50mL overnight cultures of 
BL21(DE3)pLyspRSETA-CK-2 was used to inoculate 300mL and 500mL of SOB in 1L 
Erlenmeyer as well as 1L of media in 2.8L Fernbach flasks. Cultures were grown in a 37°C 
water bath with shaking until they reached an OD600 of 0.5. Cultures were induced with IPTG 
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to a final concentration of 0.1mM then returned to the water bath for an additional 5hrs. Cells 
were pelleted at 10,000rpm for 15 mins in the Sorvall centrifuge with an SLA-1500 rotor and 
stored at -80°C before purification (described below). In order to determine the optimal 
temperature for recombinant CK-2 production 300mL of SOB in 1L flasks were inoculated 
with the cell pellet from a 50mL overnight culture of BL21(DE3)pLyspRSETA-CK-2 and 
grown in a water bath at 37°C until it reached an OD600 of 0.5. Cultures were induced with 
IPTG to a final concentration of 0.1mM and incubated at temperatures of 23°C, 30°C and 
37°C for an additional 5hrs. Cells were pelleted at 10,000 rpm for 15 mins in the Sorvall 
centrifuge fitted with an SLA-1500 rotor. Pellets were stored at -80°C until protein 
purification was performed (described below). 
2.1.5 Purification of Recombinant CK-2 under Native Conditions 
Cell pellets were thawed on ice for ten minutes and resuspended in 8mL phosphate-buffered 
saline with protease inhibitor cocktail (Roche, ON, Canada). Cells were lysed by subjecting 
the cell suspensions to six freeze-thaw cycles in dry ice and a 42°C water bath. Cell lysates 
were centrifuged in a floor model Sorvall centrifuge with a SS-24 rotor (Thermo Scientific, 
MA, USA) at 21000rpm at 4°C until a solid pellet formed, approximately 25 min. The 
supernatant was collected and purified using Ni-Nitrilotriacetic acid (NTA) resin (Qiagen, 
ON, Canada). The 50% resin slurry was added to the supernatant in a 1:4mL ratio and 
incubated on an end-over-end shaker for for 1hr at 4°C. The resin was washed eight times 
with 10mL of wash buffer containing. Recombinant protein was eluted from the resin in 
three 1mL elutions with elution buffer containing. Samples of the flow-through, washes and 
elutions were stored at 4°C for SDS-PAGE. Elutions were transferred into dialysis tubing 
and dialyzed in phosphate-buffered saline for 1hr at 4°C to remove imidazole from the 
samples. 
2.1.6 Quantification of Protein 
Protein concentrations of the elutions were determined via the Bradford Assay (Sambrook et 
al., 1989). A standard curve was constructed using known concentrations of bovine serum 
albumin (BSA) (Sigma, MO, USA), ranging from 0mg/mL to 120mg/mL in a 96-well plate. 
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All standards and samples were diluted to 25% 1N NaOH and 20% Bradford reagent (Bio-
Rad, CA, USA), in triplicate. The plate was shaken for 1min, incubated at room temperature 
for 1hr, then read at 595nm using the Versamax micro-plate reader (Molecular Devices, CA, 
USA). The standard curve was plotted with protein concentrations on the x-axis and 
absorbance at 595nm on the y-axis.  Protein concentrations of the samples were determined 
by extrapolation from the standard curve. Dialyzed elutions were diluted to protein 
concentrations of 250µg/mL and stored in 100µL aliquots at -20°C. 
2.1.7 Western Blotting and Immunodetection for the Confirmation of the Presence of 
Recombinant CK-2 
Samples from the flow-through, washes and elutions of the recombinant protein purification 
were run on an SDS-polyacrylamide gel as described in section 2.1.2. Instead of staining gels 
in Coomassie Blue, some were transferred to nitrocellulose membranes (Bio-Rad, CA, USA) 
for specific detection of bands with the use of antibodies in Western Blots. Nitrocellulose 
membranes, gels and extra thick blot papers (Bio-Rad, CA, USA) were soaked in transfer 
buffer (25mM Tris, 192mM glycine, 20% methanol) for 30min, 15min and 40sec, 
respectively. Transfer sandwiches were assembled as follows: blotting paper, membrane, gel, 
blotting paper. Sandwiches were placed in a semi-dry transfer unit (Bio-Rad, CA, USA) and 
transfer buffer was pooled on top. Transfer of proteins from the gels to the nitrocellulose 
membranes occurred at 20V for 25mins. Membranes were blocked in fetal bovine serum 
(FBS) (Sigma, MO, USA) for 48hrs at 4°C. Membranes were allowed to equilibriate to room 
temperature for 30mins then rinsed with Tris-Buffered Saline-Tween-20 (TBST) (20mM 
Tris, 300mM NaCl, 0.1% Tween-20). Rabbit anti-CK-2 antibody was used to probe the 
membranes at a final dilution of 1:3000 at room temperature. After 1hr, membranes were 
subjected to two 10sec washes, a 15min wash and two 10min washes in TBST. Membranes 
were further probed with mouse anti-rabbit secondary antibody (Sigma, MO, USA) diluted 
1:10000 in FBS for 1hr at room temperature. They were then washed in TBST for two 10sec 
washes, a 10min wash, and two 5min washes. Bands were detected with alkaline phophatase 
detection solution (52.4mM Tris, 52.4mM NaCl, 26.2mM MgCl2, 1.1% 4-nitro blue 
tetrazolium chloride (NBT) (Roche, ON, Canada), 0.17% 5-bromo-4-chloro-3-indolyl 
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phosphate (BCIP) (Roche, ON, Canada) for 2min. Membranes were rinsed in MilliQ water 
and allowed to sit in fresh MilliQ water for 2min to intensify the bands. 
2.2 Chemotaxis Assays 
2.2.1 Maintenance of RTS-11 Cells 
The rainbow trout spleen cell line RTS-11 was generously provided by Dr. Niels Bols. The 
cells were maintained in L-15 media (Thermo Scientific, ON, Canada) including 15% fetal 
bovine serum (Sigma, MO, USA) and 1% penicillin + streptomycin (Sigma, MO, USA) in 
25cm
2
 flasks (BD Biosciences, CA, USA). The cells were passaged 1:2 every 3-4 weeks and 
topped up with media, then stored in a 20°C incubator. 
2.2.2 Preparation of RTS-11 Cells 
RTS-11 cells were harvested by scraping the bottom of cell culture flasks with the use of a 
sterile cell scraper (BD Biosciences, ON, Canada). The growth media was transferred into a 
15mL falcon tube (VWR, ON, Canada) and cells were pelleted at 440xg for 5min in a 
benchtop centrifuge (Eppendorf, ON, Canada). The supernatant was aspirated and the cell 
pellet was resuspended in fresh L-15 media, including 15% FBS and 1% 
penicillin/streptomycin. Cells were counted using a haemocytometer and diluted in media to 
10 million cells per mL. 
2.2.3 Collection of Blood Samples 
Rainbow trout were kept in tanks in the University of Waterloo Department of Biology 
WetLab facility. Fish were anaesthetized in a 0.001% 2-phenoxyethanol (Sigma-Aldrich, 
ON, Canada) water bath. 5mL of blood was drawn from the caudal vein with a 23G needle 
(Fisher Scientific, ON, Canada) heparinized in 200units/mL heparin-saline solution (Sigma-
Aldrich, ON, Canada) and kept on ice until peripheral blood leukocyte isolation. 
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2.2.4 Preparation of Protein Samples 
Recombinant β2M fragment (β2Mf) was expressed and purified as described in sections 
2.1.3 and 2.1.4 for the production of recombinant CK-2. Protein aliquots were thawed on ice 
and diluted to appropriate concentrations with sterile MilliQ water. 
2.2.5 Chemotaxis Assay 
The chemotaxis assay was performed using a 48-well micro chemotaxis assembly (Neuro 
Probe, MA, USA) (Figure 2.1). Recombinant CK-2 was administered to the lower chambers 
of the apparatus in concentrations of 1µg/mL, 500ng/mL, 100ng/mL and 50ng/mL, in 
triplicate. Recombinant human C5a (Cedarlane, ON, Canada) at a concentration of 100ng/mL 
and 1X PBS were used as positive and negative controls, respectively. Recombinant β2Mf 
was used as a negative control to rule out the possibility of chemotaxis due to a component of 
the recombinant protein production. A polyvinylpyrrolidone (PVP)-free polycarbonate filter 
(Neuro Probe, MA, USA) with 5μm pores was placed in between the upper and lower 
compartments. The upper wells were filled with 50μL of the RTS-11 cell suspension. The 
assembly was covered and incubated at room temperature for 2hrs. The cell suspensions were 
then aspirated from the upper wells. The membrane was allowed to dry upside-down until all 
liquid was evaporated, fixed in methanol for 1min, and stained in 0.1% toluidine blue O 
(TBO) (Sigma, ON, Canada) for 5min. The membrane was rinsed in deionized water and 
mounted on a microscope slide. Cells that had migrated across the membrane towards the 
chemoattractant were visualized at 400x magnification using a light microscope that was 
equipped with a digital camera. Pictures were taken of three fields of view for each well. The 
average of the number of cells in each field of view in all three wells of the same dose of CK-
2 was taken. A chemotactic index was determined by calculating the ratio of the number of 
cells that showed chemotaxis to the number of cells that randomly migrated towards the 







Figure 2.1: Set-up of the Chemotaxis Assay. (A) Schematic of the 48-well chemotaxis 
chamber used in the chemotaxis assay. Substances to be tested for chemotactic ability are 
placed in the wells of the bottom chamber. A PVP-free polycarbonate membrane with 5μm 
pores is sandwiched between the top and bottom chambers. Cells are placed in the wells of 
the top chamber. The assembly is incubated for 2hrs before staining the cells on the 
membrane. Chemotaxis is defined in this assay as the migration of cells across the 
membrane. (B) The triplicate set-up of the chemoattractants in the dose-response chemotaxis 




























2.3 In vitro Expression Study 
2.3.1 Preparation of RTS-11 Cells 
RTS-11 cells were harvested by pelleting cells at 440xg for five minutes. Cells were 
resuspended in fresh media and counted using a hemocytometer. Cell suspension was used to 
seed 12.5cm
2
 flasks (BD Biosciences, CA, USA) with 5 million cells and topped up with 
media to 3mL each. Cells were allowed to settle overnight at 20°C. 
2.3.2 Treatment of RTS-11 Cells with rCK-2 
The next day, each flask was treated with varying doses of recombinant CK-2 for varying 
lengths of time, according to Table 2.1, designed to observe time course and dose-response 
effects of the chemokine on the cell line. All flasks were dosed at the same time and then 
returned to 20°C until it was time to harvest. Cells were harvested by pelleting at 440xg for 
three minutes and washed in 600μL 1X PBS. 
2.3.3 RNA Extraction 
Total RNA extraction was performed using the Qiagen RNeasy Mini Kit (Qiagen, Germany), 
as per the manufacturer‟s protocol. RNA was aliquotted and flash-frozen in dry ice and 
stored at -80°C. RNA concentration was determined by measuring absorbance of each 
sample at a light wavelength of 260nm using a NanoDrop ND-1000 (Thermo Scientific, ON, 
Canada). 
2.3.4 Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) 
RNA samples were thawed on ice and 500ng was used to synthesize cDNA using the 
Fermentas RevertAid H-minus First Strand cDNA Synthesis Kit (Fermentas, ON, Canada), 










Table 2.1: CK-2 Treatments on RTS-11 







1 100 0 
2 100 30 
3 100 60 
4 100 75 
5 100 90 
6 100 105 
7 100 120 
8 100 150 
9 100 180 






11 0 120 
12 5 120 
13 10 120 
14 50 120 
15 100 120 
16 500 120 
17 1000 120 
 
2.3.5 Amplification of Expressed Genes via PCR 
cDNA samples were used as template DNA to amplify various immune genes via PCR. Each 
reaction consisted of 1X Incubation Buffer, 1.5 mM MgCl2, 200μM dNTPs (Fermentas, ON, 
Canada), 0.4μM forward primer, 0.4μM reverse primer, 0.2μL Taq Polymerase (Fisher 
Sceintific, ON, Canada) and 1μL of cDNA. PCR amplification of each gene was carried out 
using the primers, annealing temperatures (Ta) and elongation times (te) listed in Table 2.2. 
The thermal cycler was programmed for 45 sec at 95°C, followed by cycles of 30 sec at 
95°C; 1 min at the appropriate Ta; te at 72°C, then a final elongation time of 5 min at 72°C. 
PCR products were store at 4°C. Expression profiles of each gene were compared to an 
 
 25 
internal control, 28S rRNA (Denz and Dube, 2005). PCR products for each gene were run on 
a 1.5% agarose gel in 0.5X TAE with 0.003% GelRed (Biotium, CA, USA) at 50V for 55 
minutes, with internal controls. Gels were visualized with an Alpha Innotech UV 
transilluminator and EtBr filter (Cell Biosciences, CA, USA). Densitometry analysis on the 
bands was performed using ImageJ, a program developed at the National Institute of Health 
(NIH). The bands of each gene for every sample were compared to the 28S amplified band of 
the corresponding sample, run on the same gel. 
 





















































2.3.6 Data Analysis 
The relative expression level of each gene in each sample was determined by calculating the 
ratio of the band density of the gene at that sample to the density of the corresponding 28s 
rRNA band. Time course and dose response graphs were plotted using the relative expression 
levels with error bars representing standard deviation between two independent trials. 
Trendlines were constructed from the moving averages of the relative expression level of the 
gene in a particular sample and the sample preceding it. In order to identify significant 
changes in the expression levels of each gene during the time course and the dose response, 
time course points and doses were divided into two groups that represented lower and higher 
expression levels or vice versa, depending on the response of the gene to rCK-2. The average 
gene expression level at each time point or dose in either group was calculated for each gene. 
Multiple time point and dose divisions were tested to determine the time point or dose at 
which there was the most significant change in average expression level between groups. The 
Student‟s T-test was performed to identify significant changes. The time point or dose that 
provided the point of division of the two groups that showed the most significant change in 
average expression levels was used as the time point or dose at which treatment with rCK-2 






3.1 Expression of Recombinant CK-2 
The pRSET A vector containing the CK-2 cDNA sequence was transformed into the 
BL21(DE3)pLysS strain of Escherichia coli. A time course assay revealed that the optimal 
induction time for recombinant CK-2 expression is 5hrs, displayed in Figure 3.1. Once the 
induction time was established, more trials were conducted to determine the most 
advantageous conditions for protein production. Aeration conditions were optimized for 
rCK-2 expression by comparing different volumes of media in two types of flasks (Figure 
3.2). The production of rCK-2 in cultures that were grown in 300mL and 500mL of media in 
1L Erlenmeyer flasks, as well as 1L of media in 2.8L Fernbach flasks, was examined and 
comparisons were made. It appeared that cultures that were grown in 300mL of media in 1L 
Erlenmeyer flasks produced the most protein. In order to determine the temperature that 
yielded the highest concentration of recombinant protein, there was an assessment of the 
incubation of cultures after induction at three different temperatures: 23°C, 30°C and 37°C 
(Figure 3.3). It was found that the culture that had been induced in a 37°C water bath gave 
the highest concentration of rCK-2 compared to the other incubation temperatures. Two 
300mL cultures induced at each temperature of 23°C, 30°C and 37°C, cumulatively produced 
recombinant protein concentrations of 118µg/mL, 93µg/mL and 141µg/mL, respectively. It 
was therefore concluded that the conditions favouring rCK-2 production included growing 








Figure 3.1: Time course of recombinant CK-2 expression in BL21(DE3)pLysS E. coli 
cells. The E. coli strain BL21(DE3)pLysS was transformed with the expression vector 
pRSETA that had the coding sequence of CK-2 cloned into it. An overnight culture of the 
bacteria was used to inoculate fresh media and allowed to grow until it reached an optical 
density of 0.52 at 600nm. A t=0 sample was taken at this point in order to determine baseline 
expression. Bacteria were then induced to produce recombinant CK-2 with IPTG. Samples of 
the culture were taken at every hour for 8hrs, after which they were taken every 3hrs until 
hour 23. A final sample was taken at 24hrs. All samples were pelleted and frozen 
immediately after collection. Pellets were then resuspended and put through six freeze-thaw 
cycles. Samples were centrifuged and the supernatants were run on a 12% SDS-PAGE gel, 
which was stained in Coomassie Blue. The expected size of His-tagged recombinant CK-2 













































Figure 3.2: Determination of optimal aeration conditions for the production of 
recombinant CK-2. Overnight cultures of E.coli strain BL21(DE3)pLysS carrying the RPA-
cloned pRSET A expression vector were used to inoculate three scale-up conditions: (A) 
300mL of media in a 1L Erlenmeyer flask, (B) 500mL of media in a 1L Erlenmeyer flask and 
(C) 1L of media in a 2.8L Fernbach flask. Cultures were grown to an optical density at 
600nm of 0.5. rCK-2 expression was induced with IPTG at a final concentration of 0.1mM. 
Cultures were incubated in a 37°C water bath with 225rpm of shaking for 5hrs. Bacterial 
cells were pelleted, resuspended in PBS and freeze-thawed six times. Recombinant protein 
was isolated via its 6X His-tag using Ni
2+
-column chromatography. Samples from each stage 
of the purification were run on a 12% SDS-PAGE gel and stained with Coomassie Blue. FT 












































Figure 3.3: Optimization of temperature for the production of recombinant CK-2. 
500mL cultures of BL21(DE3) pLysS pRSETA-CK-2 in 1L Erlenmeyer flasks were grown 
at 37°C until an optical density of 0.53 at 600nm was reached. Cultures were then induced 
with IPTG and incubated at 23°C, 30°C or 37°C for an additional 5hrs, then harvested and 
stored. Cell pellets were resuspended in PBS and lysed by six freeze-thaw cycles. The His-
tagged recombinant CK-2 was isolated by nickel column chromatography. Samples from 
each stage of the purification were run on 12% SDS-PAGE gels to ensure purity. Elution 
fractions that were seen to contain amounts of purified protein were analysed by the Bradford 
Assay to determine their protein concentrations. (A) Two cultures incubated at 23°C 
cumulatively produced 118µg/mL of purified protein. (B) A concentration of 93µg/mL of 
purified protein was attained from the first elution fraction of two cultures that were 
incubated at 30°C. (C) The highest concentration of protein was produced by two cultures 












































3.2 Purification of Native Recombinant CK-2 
The first step in protein isolation is to lyse the cells and so various methods of lysing 
BL21(DE3)pLysS pRSETA-rCK-2 were assessed in order to determine which method 
allowed for the cleanest purification as well as the highest yield. Methods of cell lysis that 
were tested included incubation with lysozyme followed by vortexing or sonication, 
incubation with urea in conjunction with either vortexing or sonication, incubation with 
guanidine-HCl followed by vortexing, and a method of six freeze-thaw cycles in dry ice and 
a 42°C water bath (Figure 3.4). It was found that the cleanest elutions were produced when 
cell pellets were resuspended in PBS and subjected to the freeze-thaw treatment. 
3.3 Confirmation of the Presence of rCK-2 
In order to ensure that the recombinant protein that has been produced was in fact 
recombinant CK-2, a Western blot using specific antibodies against CK-2 was performed 
(Figure 3.5). Samples from each fraction of the rCK-2 purification protocol were run on a 
12% SDS-PAGE gel and transferred to a nitrocellulose membrane. The blot was probed with 
rabbit anti-rainbow trout rCK-2 that had been produced previously. The antibody has 
previously been confirmed to be specific to rainbow trout recombinant CK-2 as it is able to 
block the action of rCK-2 in chemotaxis assays (Eshaque et al., unpublished). The secondary 
antibody was conjugated to alkaline phosphatase which reacted with 5-Bromo-4-Chloro-3‟-
Indolyphosphate p-Toluidine Salt to produce a coloured product. It was shown that the band 
of interest in the Coomassie-stained gels was indeed recombinant CK-2. In addition, none of 









Figure 3.4: Determination of the optimal method of lysing cells to obtain the cleanest 
elution in rCK-2 purification. 25mL cultures of recombinant CK-2 producing E.coli were 
grown to an optical density at 600nm of 0.5. They were induced with IPTG and grown for 
3hrs then harvested and stored at -80°C. The cell pellets were thawed on ice for 15 mins, then 
tested for the best method of lysis. Six different methods were assessed to determine which 
would retain the most rCK-2 in the cleanest fractions. (A) Lysis by lysozyme in conjunction 
with vortexing provided clean elutions but very little of the protein of interest. (B) A thick 
band was seen at the expected molecular weight of rCK-2 along with many other 
undetermined bands in the elution samples when cells were treated with lysozyme and 
sonication. In addition, it appeared that recombinant CK-2 was being lost in the washes. 
Interestingly, a band at the expected molecular weight was only seen in the third elution 
when cells were treated with urea and either (C) vortexing or (D) sonication. However in 
both cases, elutions were not as clean as desired. (E) The treatment of guanidine 
hydrochloride produced the least amount protein. (F) The cleanest elution with a 
considerable band of interest was produced by the cell pellet that had been resuspended in 
PBS then put through six freeze-thaw cycles on dry ice and in a 42°C water bath. FT = flow-





















































Figure 3.5: Verification of rCK-2 production by a Western blot probed with specific 
antibodies made against rCK-2. Samples were taken from each stage of the purification 
protocol and run on a 12% SDS-PAGE gel. The protein was transferred to a nitrocellulose 
membrane. The membrane was blocked with fetal bovine serum and probed with a 1:3000 
dilution of rabbit anti-rainbow trout CK-2. It was then incubated with a 1:10000 dilution of 
alkaline phosphatase-conjugated mouse anti-rabbit IgG. rCK-2 was detected by the coloured 




















































3.4 Production of Recombinant β2M fragment 
Recombinant β2Mf was made to use as a negative control in the chemotaxis assay. This was 
to control for the presence of chemotactic agents that may occur in the recombinant protein 
production and purification protocols, since β2M has no inherent chemotactic ability 
(Eshaque et al., Unpublished). BL21(DE3)pLysS E.coli was transformed with pRSET A 
expression vector carrying the partial coding sequence of β2M. Cultures of this strain were 
grown to an optical density at 600nm of 0.47. They were then induced to a final 
concentration of 1mM of IPTG and incubated for 5hrs in a 37°C shaking water bath. 
Bacterial cells were harvested then lysed through six freeze-thaw cycles, as described 
previously. rβ2Mf was isolated from the lysate by nickel column chromatography via its 6x 
His-tag. To confirm the presence of rβ2Mf in the elutions, samples from each step in the 
purification were run on a 12% SDS-PAGE gel and transferred to nitrocellulose membrane. 
rβ2Mf was detected in all three elutions on the Western blot by rabbit anti-rainbow trout 
β2Mf (Figure 3.6B). In addition, a similar gel that was stained with Coomassie Blue, showed 
that the elutions were fairly clean (Figure 3.6A). 
















Figure 3.6: Confirmation of recombinant β2M fragment production and purification. 
Two 500mL cultures of BL21(DE3)pLysS transformed with pRSETA-β2Mf were grown to 
an optical density at 600nm of 0.47. Cultures were induced with IPTG to a final 
concentration of 1mM, and incubated at 37°C for 5hrs. Cells were harvested and stored at -
80°C. Cell pellets were lysed by six freeze-thaw cycles and recombinant protein was isolated 
from the lysate via its 6x His-tag, using nickel column chromatography. Samples from each 
stage of the purification were run on 12% SDS-PAGE gels and either (A) stained with 
Coomassie Blue or (B) transferred to a nitrocellulose membrane. The blot was blocked with 
fetal bovine serum and probed with rabbit anti-rainbow trout β2Mf. It was then incubated 
with goat anti-rabbit IgG conjugated to alkaline phosphatase, which reacted with BCIP and 
NBT to form a coloured product indicating the presence of rβ2Mf. FT = flow-through, W = 
































3.5 Determination of the functionality of recombinant CK-2 purified under 
native conditions 
Chemotaxis assays were conducted in order to determine whether the recombinant CK-2 that 
was produced and purified under native conditions was functional (Figure 3.7). The rainbow 
trout spleen cell line, RTS-11, is known to respond to CK-2 and was used to test the 
chemotactic ability of the recombinant protein (Eshaque et al., unpublished). The 
chemotactic index of rCK-2 was determined by examining the ratio of the number of cells 
that migrated across a membrane with 5µm pores in response to the chemokine, to the 
number of cells that migrated towards a negative control. There was a significant increase in 
the migration of RTS-11 cells when treated with rCK-2. Its chemotactic index peaked at 7.9 
when exposed to 500ng/mL of rCK-2 (Figure 3.7A). This was significantly different from the 
chemotactic indices of the two negative controls, PBS and recombinant β2M fragment. 
rβ2Mf was used as a negative control to ensure that chemotaxis was not induced by any 
element used in the recombinant protein production or purification protocols. rCK-2 was also 
significantly chemotactic towards RTS-11 at the other concentrations of 1000ng/mL, 
100ng/mL and 50ng/mL with chemotactic indices of 6.49, 7.18, and 6.76, respectively. 
Interestingly, rCK-2 was not as chemotactic towards isolated rainbow trout peripheral blood 
leukocytes (Figure 3.7B). However, it was still able to attract significantly more cells across 
the synthetic membrane than the negative controls. The recombinant chemokine had a 
maximum chemotactic index of 4.75 when used at a concentration of 100ng/mL. In order to 
reinforce the hypothesis that cells were migrating due to the chemokine, RTS-11 was blocked 
with pertussis toxin (PTX) in order to inhibit their G-protein coupled receptors. As expected, 
these cells had a significantly lower migration rate towards rCK-2 than cells that had not 
been treated with the toxin (Figure 3.7C). In fact, there was a 43% decrease in movement 







Figure 3.7: Confirmation of the functionality of the recombinant CK-2 purified under 
native conditions. Chemotaxis assays were conducted in order to determine whether or not 
our rCK-2 was chemotactic. We assessed how effective it was in attracting rainbow trout 
leukocytes and inducing them to migrate across a membrane. This was measured by a 
chemotactic index which is ratio of the number of cells that migrate towards a 
chemoattractant to the number of cells that migrate towards a negative control.  (A) When 
used as the chemoattractant in a chemotaxis assay with RTS-11 cells, rCK-2 had a high 
chemotactic index in comparison to PBS (p < 5x10
-6
) as well as the recombinant β2M 
fragment (p < 10
-6
) (n=9). In addition, there was no significant difference in chemotactic 
index between the positive control, C5a, and rCK-2 at 100ng/mL and 500ng/mL (n=9). (B) 
The chemoattractant properties of rCK-2 were also tested against rainbow trout PBLs. In this 
case, its chemotactic index at concentrations of 500, 100 and 50ng/mL was also significantly 
higher than that of PBS (p < 5x10
-4
) and β2M fragment (p < 5x10
-4
) (n=9). Conversely, there 
was no significant difference in chemotactic index at concentrations of 500, 100 and 
50ng/mL of rCK-2 and the positive control (p > 0.1). (C) RTS-11 that had been blocked with 
pertussis toxin to a final concentration of 100ng/mL, showed significantly less migration 
towards rCK-2 than untreated cells (p = 2.3x 10
-12
). (D) PTX-treated rainbow trout PBLs also 



































3.6 In vitro Expression Study 
In order to determine the function of CK-2 in the immune system, its effects on the 
expression of immune-related genes in RTS-11 were examined. Cells were exposed to native 
recombinant CK-2 in time course and dose response experiments. A final exposure 
concentration of 100ng/mL was chosen for the time course and dose response samples were 
incubated for 2rhs. Total RNA was extracted from each time course and dose response 
sample and used to synthesize cDNA. Polymerase chain reaction was then conducted on each 
cDNA sample to amplify various immune-related genes. Gels for each gene were run with 
their PCR products amplified from cDNA of all time course and dose response samples, as 
well as products from the PCR amplification of the internal control, 28s rRNA (Figures 3.8, 
3.11, and 3.14). Band intensities were measured by densitometry and used to calculate 
relative expression levels by taking the ratio of gene band density to the band density of 28s 
for the same time or dose sample. The relative expression levels were used to construct time 
course and dose response curves. These allowed us to examine how each gene was affected 
by rCK-2. 
The expression of pro-inflammatory genes IL-1β, and TNFα showed 33.3% and 23.6% 
increases, respectively, after 90 mins of exposure to rCK-2 (Figure 3.9). The relative 
expression level of IL-8 in response to rCK-2 increased 27.3% after 105 mins of exposure 
(Fiugre 3.9). There was a significant 64.5% increase in IL-1β transcript level and a 12.6% 
increase in TNFα expression when cells were exposed to 1000ng/mL of recombinant protein 
(Figure 3.10A and B). However, IL-8 expression decreased by 45% when treated with 5-
500ng/mL of CK-2. Interestingly, expression of IL-8 returned to basal level at 1000ng/mL 
(Figure 3.10C). 
Firstly, the expression levels of MHIα, IFN1 and IFN2 were examined in order to determine 
the role of CK-2 in the immune response against intracellular pathogens. Increases in the 
transcript levels of all three genes were seen after 105 mins of exposure (Figure 3.12). The 
26.9 and 31.5% increases in MHIα and IFN2 expression were significant at the 0.01 level. 
IFN1 increased by 32%, which was significant at the 0.05 level. There seemed to be no 
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statistically significant dose response effect of CK-2 on MHIα but expression levels of the 
interferons were seen to decrease at higher concentrations of the chemokine (Figure 3.13). 
IFN2 only decreased by 11.5% at concentrations of 10-1000 ng/mL but IFN1 expression 
decreased by 47.4% at 5-500ng/mL and returned to basal levels at 1000ng/mL of rCK-2. 
The effect of CK-2 on the immune response to extracellular pathogens was also assessed, by 
looking at the time courses and dose responses of MHIIα, S25-7 and CD4 expression. 
Transcription of MHIIα and CD4 increased by 36.6 and 25.8% respectively, after 90 min of 
incubation and were both significant at the 0.01 level (Figure 3.15A and C). Interestingly, 
rCK-2 did not appear to have a significant effect on S25-7 (Figure 3.15B). However, there 
was no significant dose response effect on any of the three genes (Figure 3.16). 
Since RTS-11 is a heterogeneous cell line consisting of both monocyte-like and macrophage-
like cells, it was important to determine if the effects on immune-related gene expression was 
being seen in one or the other, or both cell populations. A separate flask of RTS-11 that was 
seeded at the same time from the same culture as the samples used in the time course and 
dose response experiments, were sorted by flow cytometry. Cell sorting was conducted based 
on size and granularity since the monocyte-like cells are small and non-granular while the 
macrophage-like cells are larger and contain granules. It was seen that the cell population of 













Figure 3.8: RTS-11 expression profiles of pro-inflammatory genes in response to rCK-2. 
10
6
 cells were seeded in 6mL of L-15 media with 10% FBS and 1% penicillin/streptomycin 
and allowed to equilibrate at 20°C overnight. Each flask of cells in the time course was 
treated with 100ng/mL of rCK-2 then incubated at 20°C for varying times, while the dose 
response samples were incubated for 120 mins with the indicated doses of recombinant 
protein. Total RNA was collected from each flask of cells and converted to cDNA. Time 
point and dose cDNA samples were used as template DNA for PCR amplification of pro-
inflammatory genes IL-1β, TNFα and IL-8, as well as an internal control gene, 28s rRNA. 
Products for all (A) time course and (B) dose response samples of a gene were run on a 1.5% 
agarose gel stained with GelRed, in 0.5X TBE for 55mins at 35V, along with the products of 
28s. Band densities of each sample were measured by densitometry and compared to their 







































Figure 3.9: Time course of relative pro-inflammatory gene expression in RTS-11 
treated with recombinant CK-2. The relative expression levels of IL-1β, TNFα and IL-8 
over 240 mins from two trials were averaged. Error bars represent the standard deviation 
between trials. A trendline (red) was constructed from moving averages calculated from two 
time points. Based on the trendline, samples with baseline expression versus induced 
expression levels could be clearly distinguished (purple boxes). The average expression 
levels of each category (yellow) were taken in order to ascertain the degree to which 
expression was affected by rCK-2. Student‟s two-sample t-tests were used to determine 
significant differences in expression levels. (A) Relative IL-1β expression time course 
showed a significant increase after 90 mins of exposure to rCK-2 (p=0.0023). (B) TNFα 
expression relative to 28s, increased significantly after 90 mins (p=0.000921). (C) A 
Student‟s t-test showed that 105 mins of treatment with rCK-2 was sufficient to cause a 































Figure 3.10: Dose response of pro-inflammatory genes to rCK-2 in RTS-11. The average 
relative expression levels IL-1β, TNFα and IL-8 in response to 0, 5, 10, 50, 100, 500 and 
1000 ng/mL of recombinant chemokine are shown (blue), along with standard deviations as 
error bars (n=2). Trendlines (red) were constructed from moving averages between two doses 
and were used to determine baseline and induced expression (purple). The average baseline 
and induced expression levels (yellow) were used to assess how pro-inflammatory gene 
expression was affected by rCK-2. One sample t-tests were used to detect significant 
changes. (A) Relative IL-1β expression at various doses of recombinant CK-2, which was 
seen to increase significantly at 1000ng/mL of CK-2 (p=0.00066). (B) The small increase in 
TNFα expression level in response to 1000ng/mL of rCK-2 was significant at the 0.05 level 
(p=0.016). (C) IL-8 expression relative to 28s decreased significantly at doses of rCK-2 of 5-
































Figure 3.11: Expression profiles of intracellular pathogen immune response genes in 
RTS-11 treated with rCK-2. Ten million cells were seeded at a cell density of 1.67 million 
cells per mL in L-15 media enhanced with 10% FBS and 1% penicillin/streptomycin for each 
sample. Cells were allowed to settle overnight in a 20°C incubator. Time course samples 
were treated with 100ng/mL of rCK-2 then incubated at 20°C for varying times, while the 
dose response samples were treated with the indicated doses of protein and incubated for 120 
mins. cDNA was synthesized from 500ng of total RNA that was harvested from each sample, 
which served as template for PCR amplification of MHIα, IFN1 and IFN2 and the internal 
control, 28s. PCR products of all samples from (A) the time course and (B) the dose response 
were run on a GelRed-stained 1.5% agarose gel in 0.5X TBE at 34V for 55 mins for each 
gene, along with those of the internal control. Densitometry analysis was performed for each 
band. Relative gene expression levels were determined by comparing the band densities of 







































Figure 3.12: Time course of relative expression of immune-related genes associated with 
intracellular pathogens in RTS-11 treated with rCK-2. The ratios of the band densities of 
MHIα, IFN1 and IFN2 to 28s for each sample were averaged between two trials and plotted 
with standard deviations. Moving averages using two time points were used to construct a 
trendline (red). From this, baseline and induced expression levels could be distinguished 
(purple boxes) and averaged in order to determine the degree to which rCK-2 affected gene 
expression (yellow). (A) The Student‟s two-sample t-test showed that there was a significant 
increase in MHIα expression after being treated with rCK-2 for 105 mins (p=0.0044). (B) 
The increase in IFN1 at 105 mins of rCK-2 exposure was significant at the 0.05 level 
(p=0.012). (C) IFN2 transcript level showed a significant increase after 90 mins of 


































Figure 3.13: Dose-response expression of intracellular pathogen immune response-
related genes in RTS-11 exposed to rCK-2. The relative expression levels of MHIα, IFN1 
and IFN2 in RTS-11 treated with increasing doses of recombinant CK-2 from two trials were 
averaged. Error bars represent standard deviations. A trendline was constructed based on 
moving averages between two samples (red) and from this, baseline and induced expression 
levels were determined (purple). (A) A Student‟s two-sample t-test showed that the apparent 
increase in relative MHIα expression level was not significant (p=0.12). (B) IFN1 was seen 
to decrease significantly when treated with doses of 5-500ng/mL of rCK-2 (p=0.0011). (C) 
IFN2 also showed a slight decrease in expression that was significant with doses of rCK-2 of 



































Figure 3.14: Extracellular pathogen immune-response related gene expression profile of 
RTS-11 exposed to rCK-2. RTS-11 cells were seeded in L-15 media with 10% FBS and 1% 
penicillin/streptomycin at a cell density of 1.67 million cells/mL and allowed to rest 
overnight at 20°C. Each flask contained 10
6
 cells and was treated with 100ng/mL of rCK-2 
for each time point in the time course and for 120 mins with each dose in the dose response. 
Total RNA was collected from each sample and 500ng of each RNA sample was converted 
into cDNA. Amplification of MHIIα, S25-7 and CD4 were performed via PCR with each 
cDNA sample. GelRed stained 1.5% agarose gels were run with the products of these PCR 
reactions of each gene for each (A) time point and (B) dose, with the products of 28s 
amplification. Densitometry analysis was used to quantitate the expression levels of the 
genes in each sample. Expression levels were compared to the internal control to obtain 








































Figure 3.15: Relative expression time course of genes related to extracellular pathogen 
immune response in RTS-11 cells dosed with rCK-2. The average expression levels of 
MHIIα, S25-7 and CD4 relative to 28s expression in RTS-11 exposed to recombinant CK-2 
are displayed with standard deviations as error bars (n=2). The average expression level 
between two time points was used to create a moving average trendline (red). Expression 
levels were designated as baseline or induced (purple boxes) based on the trendline. Baseline 
and induced expression levels were averaged (yellow) in order to determine how the immune 
response to intracellular pathogens was affected by rCK-2. (A) A Student‟s two-sample t-test 
showed that rCK-2 caused an increase of significance in relative MHIIα expression after 90 
mins of exposure (p=0.0034). (B) There appeared to be no significant change in S25-7 
expression over 240 mins of treatment with the recombinant protein (p=0.082). (C) The 
































Figure 3.16: Dose response effects of rCK-2 on the relative expression levels of genes 
involved in the extracellular pathogen immune response in RTS-11. Relative expression 
levels of MHIIα, S25-7 and CD4 in RTS-11 cells dosed with 0, 5, 10, 50, 100, 500 or 
1000ng/mL of recombinant CK-2 for 120 mins. The average expression levels of two trials 
are depicted with standard deviations as error bars. Moving averages were used to construct a 
trendline (red) of the dose response, which was used to determine baseline and induced 
expression levels (purple). The average expression levels of the baseline and induced 
samples (yellow) were used to examine significant changes using two-sample t-tests. (A) 
MHIIα expression did not show any significant dose response effect in response to rCK-2 
(p=0.23). (B) There were no significant changes in relative S25-7 expression levels in any of 
the doses tested (p=0.67). (C) The perceived increase in CD4 transcript at doses of 500 and 

































Figure 3.17: Flow cytometry analysis of the heterogeneous cell line, RTS-11. (A) Two 
distinct cell types can clearly be seen under the microscope in a culture of the rainbow trout 
spleen cell line, RTS-11. The black arrow points out a typical small, round monocyte-like 
cell while the red arrow indicates a typical larger, granular macrophage-like cell. (B) In 
addition, flow cytometry can sort the cells based on size and granularity using forward and 
side scatter parameters. The two cell types are present in equal amounts in this particular 
culture of cells, which had been passaged three weeks prior to flow cytometry.  (C) A flask 
of cells that had been seeded in the same density and at the same time as the time course and 
dose response samples was harvested and fixed in 70% ethanol. These cells were analyzed by 










































4.1 Functional activity of recombinant CK-2 purified under native conditions 
As expected, the chemotaxis assays showed the functional activity of rCK-2 purified under 
native conditions. In addition, this native protein had a higher chemotactic index at lower 
concentrations than rCK-2 produced previously but purified under denaturing conditions 
(Eshaque et al., unpublished). The rCK-2 purified under native conditions had an optimal 
chemotactic index at a concentration of 100ng/mL when used in the chemotaxis assay to 
attract RTS-11 cells as well as peripheral blood leukocytes (PBLs) isolated from rainbow 
trout blood (Figure 3.7A and B). The concentration of 100ng/mL is the typical concentration 
at which most chemokines are active in vitro (Lally et al., 2003). For example, this 
concentration is also the dose at which cell migration of human peripheral blood 
mononuclear cells induced by recombinant CCL22 peaks in the chemotaxis assay (Godiska 
et al., 1997). Cells from the human osteosarcoma-derived cell line (HOS) transfected with the 
CC chemokine receptor CCR1 were also reported to migrate optimally towards recombinant 
CCL5 and recombinant CCL15 at the concentration of 100ng/mL (Kim et al., 2005). 
Interestingly, concentrations of 1ng/mL and 1000ng/mL of CCL3 and CCL16, respectively, 
were seen to provide optimal conditions for the migration of these cells (Kim et al., 2005). 
However, a study by Durig et al., showed that the optimal concentration of CCL3 was 
150ng/mL for the induction of calcium mobilization indicating chemokine stimulation in 
human peripheral blood mononuclear cells (Durig et al., 1999). The discrepancy in optimal 
concentrations of CCL3 for leukocyte stimulation may be due to the expression levels of CC 
chemokine receptors on each type of cell used in each study. The cells from the HOS cell line 
that were used in the Kim et al. study were transfected to specifically express CCR1 whereas 
Durig et al. used mononuclear cells isolated from human blood which may express less 
CCR1 than the HOS/CCR1 cells and would require a higher concentration of CCL3 for 
optimal stimulation. It was shown previously in the lab that the highest chemotactic index of 
recombinant CK-2 that had been purified under denaturing conditions was achieved at a 
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concentrations of 500ng/mL when used in the chemotaxis assay with RTS-11 cells as wells 
as PBLs (Eshaque et al., unpublished). In addition, it has been previously reported that in 
RTS-11, recombinant IL-8, a CXC chemokine, induced chemotaxis at an optimal 
concentration of 150ng/mL while cell migration peaked at a dose of 1500ng/mL of 
recombinant CC chemokine CK-6 purified under denaturing conditions (Montero et al., 
2008). It was also seen that peripheral blood leukocytes isolated from Japanese flounder 
(Paralichthys olivaceus) were attracted to recombinant CC chemokine Paol-SCYA104 that 
was purified under denaturing conditions, at an optimal dose of 1000ng/mL (Khattiya et al., 
2004). Thus, the recombinant CK-2 that was produced for this study under native conditions 
is acting within the range that has been previously reported for recombinant CC chemokines, 
including teleost chemokines, by other research groups. 
The chemotactic index of rCK-2 for PBLs was significantly lower than it was for RTS-11 
(Figure 3.7A and B). This is most likely due to the presence of other cell types in the isolated 
leukocyte fraction that were not monocytes/macrophages. Thus although the total number of 
cells used in either assay was the same, many of the cells in the PBL sample may not have 
been attracted by rCK-2. rβ2Mf was used in the chemotaxis assay as a negative control in 
order to control for the presence of chemotactic agents that may have come from the protein 
production procedure. The chemotactic index of rβ2Mf was not significantly different from 
the PBS negative control except for at the 50ng/mL concentration in RTS-11 (Figure 3.7A). 
The relatively high chemotactic index at this low concentration may be due to the presence of 
chemotactic endotoxins that came from the bacterial host, such as lipopolysaccharide, as a 
by-product of protein purifcation. It is possible that at the higher concentrations of rβ2Mf, the 
endotoxins would be bound by the protein leaving little free to stimulate chemotaxis 
(Nakamura et al., 2001). However at the lower concentration of β2Mf there is less protein to 
bind LPS, allowing more of the unbound form to cause chemotaxis. This explanation can be 
verified by testing for the presence of endotoxins in the protein samples. Chemotaxis was 
also tested in the presence of pertussis toxin, which is known to block chemokine receptor 
activity, in order to ensure that it was occurring due to rCK-2 (Figure 3.7B and C) (Viola and 
Luster, 2008; Baggiolini et al., 1997). In both assays with RTS-11 and PBLs, chemotaxis was 
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significantly lower when cells were blocked with pertussis toxin indicating that it was indeed 
occurring in response to the recombinant protein interacting with a serpentine family 
receptor. Based on the results of the chemotaxis assays performed, it can be concluded with 
confidence that the recombinant chemokine that was produced under native conditions can be 
used to examine the function and downstream effects of CK-2 in the rainbow trout immune 
system. 
4.2 Downstream Effects of rCK-2 on the Inflammatory Response 
As macrophages are among the first responders to invading pathogens and the initiators of 
the inflammatory response, the role of CK-2 in this process was examined. When 
encountered with a bacterial cell, macrophages present in the infected tissue become 
activated and release inflammatory mediators to recruit cells of the innate immune response. 
Among these are the cytokines IL-1β, TNFα and IL-8. These molecules are important in 
promoting the extravasation of neutrophils and later, monocytes, from the bloodstream. From 
the expression experiment, it was seen that the incubation of the macrophage and monocyte-
like cell line with rCK-2 led to an increase in transcript levels of IL-1β and TNFα after 90 
mins and IL-8 after 105 mins (Figure 3.9). Human monocytes induced with bacterial 
lipopolysaccharide (LPS) have previously been seen to upregulate their expression of IL-1β, 
TNFα and IL-8 mRNA in a similar pattern, beginning to increase significantly starting at 60-
90 mins of exposure (Agarwal et al., 1995). IL-1β and TNFα were seen to plateau at 120 
mins of treatment which was what was seen in RTS-11 dosed with rCK-2 (Agarwal et al., 
1995). However, expression of IL-8 in the human study continued to increase until 240 mins 
whereas IL-8 transcript levels plateau in RTS-11 (Agarwal et al., 1995). In addition, the 
induction of IL-8 in RTS-11 by rCK-2 was much lower than its upregulation in human 
monocytes by LPS (Agarwal et al., 1995). A similar IL-8 mRNA expression pattern was seen 
in porcine macrophages induced with LPS, in which there was a significant increase in 
expression at 90 mins but did not reach its peak until 7hrs (Lin et al., 1994).  All three 
cytokines began to downregulate expression after 240 mins in the human monocytes and 
except for IL-8, returned to basal levels at 24hrs which was also seen in the study with 
porcine macrophage (Agarwal et al., 1995; Lin et al., 1994). A study of IL-1β in rainbow 
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trout head kidney macrophages treated with LPS showed a dramatic increase in IL-1β 
transcript level after 240 mins of induction (Zou et al., 1999). However, this study did not 
determine when upregulation of IL-1β is initiated in rainbow trout macrophages. A 240 min 
treatment of RTS-11 with LPS was reported to significantly increase the mRNA expression 
of TNFα (Laing et al., 2001). Again, the time course of the induction of expression was not 
examined. The IL-8 transcript level in RTS-11 exposed to LPS was reported to increase 
significantly at 120 mins, peaking at 240 mins and lasting until 8hrs of treatment (Laing et 
al., 2002). The time points at which induction begins or ends were not determined in this 
study. Although it is possible that LPS induction of these pro-inflammatory cytokines begins 
earlier than the time points that were examined in these studies, it is also possible that 
chemokine-induction of pro-inflammatory gene expression begins earlier than LPS-driven 
stimulation. However similar to the studies of LPS-treated monocytes/magrophages, 
upregulation of IL-1β in human monocytes upon exposure to CCL5 was only examined and 
observed after 120 mins (Locati et al., 2002). RTS-11 dosed with the CC chemokine CK-6 
were reported to upregulate IL-8 expression at the transcript level at 24hrs but the time 
course prior to this was not determined (Montero et al., 2008). In addition, IL-1β and TNF-α 
were not induced by CK-6 at the 24hr time point but it is possible that the increase in 
expression of these cytokines occurs earlier (Montero et al., 2008). Nevertheless, the induced 
expression of IL-1β, TNF-α and IL-8 in RTS-11 treated with rCK-2 was seen in this study to 
begin at 90 mins and lasted until the end of the time course examined. 
The time courses of IL-1β, TNFα and IL-8 mRNA expression in RTS-11 in response to rCK-
2 were similar to those seen in human, porcine and rainbow trout macrophages treated with 
LPS. However, the induction of IL-8 expression was not as high in cells exposed to rCK-2 as 
cells exposed to LPS. This difference could be due to the role of IL-8 in inflammation as a 
CXC chemokine. The reason for its secretion during an inflammatory response is primarily to 
attract leukocytes to the site of infection. CXC chemokines are responsible for directing the 
migration of neutrophils, lymphocytes and monocytes to the site of infection while CC 
chemkines mainly attract monocytes/macrophages. However, due to the presence of the ELR 
motif in IL-8, it is less effective in inducing the migration of neutrophils. It is possible that 
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macrophages in the infected tissue do not need to secrete as much IL-8 because monocytes 
are already being attracted to the site of infection by CK-2. IL-8 would still be needed to 
induce chemotaxis in lymphocytes. The overlap in target cells could be why rCK-2 did not 
elicit as large of a response in IL-8 expression that was reportedly caused by LPS. Apart 
from the lower level of IL-8 induction, rCK-2 stimulated a similar pattern of pro-
inflammatory cytokine expression in RTS-11 as was seen by the treatment of LPS on human, 
porcine and rainbow trout macrophages. This may indicate that CK-2 is a sufficient signal for 
rainbow trout macrophages to initiate an inflammatory response. 
The dose response of the expression of IL-1β, TNFα and IL-8 of RTS-11 to rCK-2 was also 
examined. The expression of IL-1β was the most augmented of the three pro-inflammatory 
cytokines and was induced at the concentration of 1000ng/mL. Likewise, the most significant 
induction of IL-1β in RTS-11 treated with rCK-6 was observed at a dose of 1500ng/mL 
(Montero et al., 2008). However, human monocytes were reported to only require 300ng/mL 
of CCL5 in order to generate a 19.5-fold upregulation of IL-1β compared to untreated cells 
(Locati et al., 2002). The statistically significant, albeit minor, increase in TNFα mRNA 
levels at 1000ng/mL of rCK-2 was not seen when RTS-11 was exposed to rCK-6 at any of 
doses that were tested in the study by Montero et al. (2008). rCK-2 elicited a decrease in IL-8 
expression at lower levels of the chemokine but did not cause a response at the 1000ng/mL 
dose. Similarly, there was a slight decrease in IL-8 transcript in RTS-11 dosed with low 
levels of rCK-6 however there was a substantial induction of the gene at the 150 and 
1500ng/mL concentrations. Thus, the dose response effect of rCK-2 on pro-inflammatory 
genes in RTS-11 reflects what was observed in studies of other chemokines on 
monocytes/macrophages. 
When a sample of untreated RTS-11 from the same passage was examined by flow 
cytometry, it was seen that the majority of the population consisted of monocyte-like cells 
(Figure 3.17). It has been previously shown that human monocytes that have begun the 
process of differentiation into macrophages, increase their production of cytokines related to 
bacterial LPS-induction (Gessani et al., 1993). In light of this, it is possible that CK-2 is also 
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involved in monocyte differentiation. If this is the case, it would be expected that exposure to 
the chemokine would induce much higher levels of IL-1β and TNFα than seen in the time 
course experiment. One possibility is that much more expression of the cytokines may be 
occurring at the protein level rather than the mRNA level. Another possibility is that the 
dramatic increase expected in the transcript level of IL-1β and TNFα happens much later in 
the time course. However, it was seen in the study of these cytokines in human monocytes 
exposed to LPS that their expression at the mRNA level begins to return to basal levels after 
240 mins, although it should be noted that the regulation of gene expression in fish may be 
vastly different than in mammals (Agarwal et al., 1995). The dose response data may 
corroborate with the hypothesis of further upregulation of the pro-inflammatory cytokines at 
a later time. It could be postulated that at low concentrations, when monocytes are still in the 
bloodstream and away from the site of infection, CK-2 has no effect on IL-1β and TNFα. 
However, once the monocytes have entered the site of infection where the concentration of 
CK-2 would be the highest, IL-1β and TNFα expression increases as CK-2 begins to induce 
their differentiation into macrophages. 
It can be surmised that CK-2 influences several aspects of the innate immune response of 
macrophages. It may induce macrophages to initiate inflammation by increasing the 
production and secretion of IL-1β, TNFα and IL-8, which facilitate the migration of 
leukocytes across the blood epithelium. CK-2 can play a role here as well, since it was seen 
in the chemotaxis assay that it is capable of inducing chemotaxis in monocytes. Once the 
monocytes have migrated into the infected tissue, they can once again be influenced by CK-2 
to differentiate into macrophages. 
At the very least, the increases in IL-1β, TNFα and IL-8 mRNA indicate that the monocytes 
are being stimulated by CK-2 (Auffray et al., 2009). However, more studies at the protein 
level of these genes must be performed in order to confirm the hypothesis that CK-2 has 
multiple roles in the innate immune response in macrophages. It is possible that the increases 
that were observed in the pro-inflammatory transcripts are not translated into protein. In 
addition, if the proteins are not secreted into the environment, they can not affect the cells 
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around them. Increased IL-1β production may also mean that there is increased IL-6 
expression downstream. Future studies should look at a rise in IL-6 transcript and protein 
levels later on in the time course, as this could indicate the involvement of CK-2 in the 
activation of the acute phase response. Similarly, iNOS expression levels and the induction 
of respiratory burst should be examined since TNFα is an inducer of NO production. 
4.3 Implication of CK-2 exposure on the rainbow trout immune response to 
intracellular pathogens 
Although the principal purpose of macrophages is traditionally thought to be the detection of 
extracellular pathogens, these cells also have a co-dependent relationship with proteins 
involved in the response against intracellular pathogens. As evidenced by the viral mimicry 
of chemokines in an attempt to evade the immune system, it is well-known that chemokines 
are extremely important in the antiviral response (Melchjorsen et al., 2003). In addition, the 
monocyte/macrophage cell lineage both produces and responds to the CC-subfamily of 
chemokines (Fantuzzi et al., 2003). In light of this, the effect of CK-2 on the expression of 
some of the antiviral response genes in RTS-11, including MH Class I α-chain, IFN1 and 
IFN2 was examined. 
As nucleated cells, monocytes/macrophages have the inherent capability of expressing MH 
Class I and presenting antigens from intracellular pathogens. The increase that was seen in 
MHIα mRNA after 105 mins of exposure may be an indication that CK-2 is capable of 
priming monocytes/macrophages to defend against intracellular pathogens. Rainbow trout 
infected with infectious hematopoietic necrosis virus (IHNV) have been reported to show 
increased expression of MHIα beginning at 72hrs post-exposure in spleen and head kidney 
(Hansen and La Patra, 2002). A study using an Atlantic salmon kidney cell line (ASK) also 
showed an increase in MHIα at 72hrs of infectious salmon anaemia virus (ISAV) infection 
(Jorgensen et al., 2006). The MHIα upregulation observed at this time point may possibly 
corroborate with the timeline of viral induction of CC chemokine expression and chemokine 
induction of MHIα. Rainbow trout infected with viral haemorrhagic septicaemia virus 
(VHSV) have been seen to express CC chemokines at 72hrs of exposure (Montero et al., 
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2009). Similarly, upregulation of CC chemokines in mice infected with influenza A virus 
were also reported to begin at 72hrs (Wareing et al., 2004). However, none of these studies 
examined the time course of expression of CC chemokines or MHIα between 24 and 72 hrs. 
It is therefore possible that CC chemokine expression is induced by viral infection prior to 
the upregulation of MHIα in the temporal vicinity that was seen in the present study. The 
time course of expression of CC chemokines and MHIα should be investigated in a finer 
detail. It has also yet to be seen whether the increase in transcript level of MHIα is also seen 
in the protein level. However, the upregulation of MHIα mRNA in response to rCK-2 could 
indicate that CK-2 is capable of triggering an immune response towards a viral infection. 
The lack of a statistically significant dose response effect of rCK-2 on MHIα may indicate 
that prolonged exposure to the chemokine is required for upregulation rather than a specific 
dose. It is interesting that there is a substantial decrease in IFN1 expression in response to 
rCK-2 which returns to basal levels at the 1000ng/mL dose. However, dose response data of 
chemokines on interferon expression could not be found for a comparison. 
The increase in interferon expression that was seen in the time course of RTS-11 treated with 
rCK-2 may provide further evidence that CK-2 could have a role in initiating an antiviral 
response. Type I interferons encompass α and β interferons, which are induced in many cell 
types, including macrophages, in response to viral infections. They operate in autocrine and 
paracrine fashions, secreted by the infected cell and act on it and surrounding infected cells to 
inhibit viral replication by inducing the expression of interferon stimulated genes (ISGs) 
(Melchjorsen et al., 2006; Kileng et al., 2007). For example, one of the genes that is capable 
of being induced by IFN1 encodes the antiviral protein Mx, which is known to interfere with 
viral replication (Kileng et al., 2007).  The 32% increase in IFN1 after 105 of exposure to 
rCK-2 indicates that CK-2 could possibly act as a signal to cells that there is a viral invasion 
and to activate to an antiviral state. Similar to MHIα, Type 1  interferons have been seen to 
be upregulated at the transcript level in spleen and head kidney of rainbow trout infected with 
VHSV starting at 48 and 72hrs of exposure, respectively (Zou et al., 2007). Kidney tissue of 
Atlantic salmon challenged with infectious pancreatic necrosis virus (IPNV) also showed an 
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increase in IFN1 and IFN2 at 72hrs then decreased in expression before peaking at day 6 
(McBeath et al., 2007). IPNV-infected cells of the rainbow trout gonad cell line (RTG-P1) 
were seen to significantly increase in IFN1 transcript level at 24hrs of treatment (Collet et al., 
2006). Likewise, an Atlantic salmon head kidney leukocyte cell line, TO cells, that had been 
exposed to ISAV showed a 10-fold increase in IFN1 at 24hr post-infection (Kileng et al., 
2007). The discrepancy in the time points at which upregulation of the interferons is seen in 
whole fish as opposed to cell lines is most likely due to the time it takes for the viral infection 
to reach the tissues capable of response. As discussed above, virus-induced chemokine 
expression has not been observed until 72hrs post-infection in whole animals. Again, the 
time course of CC chemokine expression between 24 and 72hrs of exposure to virus was not 
elucidated. Thus, CC chemokines could be expressed before the induction of the interferons 
within that window. It is also possible that viral infection could stimulate interferon 
production before the upregulation of CC chemokines which could further increase the 
expression of type 1 and 2 interferons as seen in the response to rCK-2. It would be 
interesting to see if there is an enhancement of interferon expression when RTS-11 is 
infected with virus in conjunction with exposure to rCK-2. 
It has previously been reported by DeMaeyer and DeMaeyer-Guignard that of the Type I 
interferons, macrophages mostly express IFNβ, while Saksela et al., showed that viral 
induction of IFNα is more prevalent in monocytes (DeMaeyer and DeMaeyer-Guignard, 
1988; Saksela et al., 1984). The primers that were used to amplify IFN1 were designed from 
the mRNA sequence of rainbow trout type I interferon 1 (NCBI accession number 
AJ580911.2). This sequence was compared to the National Center for Biotechnology 
Information (NCBI) nucleotide database using BLAST in order to determine whether it was 
the sequence for α or β interferon. The sequence analysis came back with 96% sequence 
identity to the Atlantic salmon IFNα1 gene, 98% sequence identity to the Atlantic salmon 
IFNα2 gene, and 100% sequence identity to an Atlantic salmon IFNα1 pseudogene. It can 
therefore be assumed that the transcript that the primers used in this study were designed 
against is that of rainbow trout IFNα. This indicates that the upregulation of Type I interferon 
in response to rCK-2 was most likely occurring in the dominating monocyte population. 
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Therefore, it is possible that CK-2 has a two-fold role in antiviral immune response. Upon 
exposure to the chemokine, monocytes are activated to help fight a viral infection that is 
taking place somewhere in the organism. They would then use the chemokine gradient to 
lead them to where the viral infection is occurring. By the time the cells reach the viral-
plagued tissue, they are primed and ready to secrete type I interferons that will interfere with 
viral replication in infected cells. At the same time, the IFN1 that is being produced by these 
monocytes/macrophages can further upregulate the expression of MH Class I (Murphy et al., 
2007).  
In addition, the autocrine production of IFN1 may ensure that cells can more readily present 
viral antigens to CD8
+
 killer T-cells by inducing the expression of proteins that are involved 
in processing foreign intracellular peptides to be loaded into the binding cleft of MHI 
molecules. These supplementary proteins include the TAP proteins, which transport cytosolic 
proteins to the endoplasmic reticulum, and the LMP proteins that are components of the 
immune-induced proteasome, or immunoproteasome which is found in interferon-induced 
cells (Murphy et al., 2007). Furthermore, the generation of peptides that are of compatible 
length for associating with the MHI binding cleft is ensured by the endoplasmic reticulum 
aminopeptidase ERAAP, which can be upregulated by IFN2 (Murphy et al., 2007). It is 
therefore plausible that CK-2 plays a role in stimulating monocytes/macrophages to prepare 
for an antiviral response. 
IFN2 is also well established as a principal influence in skewing the immune response 
towards a Type I helper T-cell mediated response. It was traditionally thought that IFN2 
expression and secretion was restricted to T-cells and natural killer cells, however a few 
studies have shown that macrophages are also capable of producing the cytokine. In 1993, 
Fultz et al., reported that murine macrophages could be induced to express IFN2 by 
lipopolysaccharide (LPS). A year later a research group in Italy published evidence that IFN2 
is constitutively expressed in resting mouse peritoneal macrophages and could even be self-
upregulated (DiMarzio et al., 1994). The same group also showed that a significant increase 
in IFN2 expression could be induced by the cytokine IL-12 and could confer antiviral 
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protection (Puddu et al., 1997). Both groups suggested that the ability of macrophages to 
both express and respond to IFN2 may indicate that autocrine activation by IFN2 is important 
for optimal immune preparedness (Fultz et al., 1993; Puddu et al., 1997). The increase that 
was seen in IFN2 expression in response to treatment with CK-2 may provide further 
evidence that the chemokine induces the cytokine to work in an autocrine fashion to activate 
an immune response against intracellular pathogens. Therefore, one of the functions of the 
chemokine may be to act as a molecular warning that an antiviral immune response needs to 
be initiated. It would be interesting to see whether the increase in IFN2 transcript gets 
translated to the protein level and whether IFN2 is secreted by the cell. It would also be 
interesting to see if CK-2 expression is substantially increased during an in vivo viral 
infection and whether anti-CK-2 antibodies can block its upregulation of interferon and 
activation of an antiviral response, however there are most likely other systems that are able 
to signal the presence of a viral threat. 
IFN1 and IFN2 are both known to prime monocytes/macrophages for the immune response 
against viral infections and increase the expression of MH Class I. However, they are 
unlikely to be responsible for the upregulation of MHIα expression that was seen in CK-2 
exposed RTS-11, since it seems to be occurring in parallel to the increase in interferon 
transcript levels. On the other hand, it may be possible that the autocrine interferons would 
further increase MHIα later on in the time course. Since MHIα is being induced relatively 
early in the time course, CK-2 may directly affect its upregulation. 
4.4 Effects of rCK-2 on genes related to the immune response to extracellular 
pathogens 
As antigen-presenting cells, it was not surprising to observe a CK-2-triggered monocyte 
response in MHIIα expression. The transcript level of MHII genes is known to correspond 
well to cell surface expression level, making it quite probable that the increase that was seen 
in response to CK-2 exposure is actually occurring (Jasinski et al., 1995). MH Class II is 
known to be upregulated in mouse macrophages by IFN2 as well as TNF-α however its 
expression is seen to be suppressed in the presence when cells are treated with LPS 
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(Glimcher and Kara, 1992). Contrary to this, the stimulation of MHIIβ expression has been 
observed in rainbow trout head kidney macrophages treated with LPS for 4hrs (Knight et al., 
1998). A study with RTS-11 exposed to LPS for 4hrs reported no apparent increase in MHIIβ 
transcript level (Brubacher et al., 2000). However, when expression of MHIIβ in control and 
treated samples is compared to the level of expression of the internal control gene, β-actin, in 
those samples, it appears that upregulation may be occurring (Brubacher et al., 2000). 
Nevertheless, LPS was also seen to induce the expression of MHIIα in the Atlantic salmon 
macrophage-like cell line (SHK-1) at 72hrs of treatment (Koppang et al., 1999). The 
upregulation of MHIIα that was seen in the present study in RTS-11 dosed with rCK-2 
starting at 90 mins of exposure may seem early compared to the previous studies. However, 
it should be noted that the expression of MH Class II genes in response to LPS was not 
examined at time points prior to 4hrs, which was the upper limit of the time course in this 
study. As well, the increased level of MHIIα was maintained until the 4hr time point in the 
rCK-2 study. 
Interestingly, the rainbow trout invariant chain S25-7 does not get upregulated along with 
MHIIin response to CK-2. Invariant chain is essential for the proper presentation of non-self 
peptides by MHII. It is known to be inducible in the mammalian immune system however, 
previous work in this lab has shown that S25-7 does not get induced in the presence of other 
immunostimulatory factors indicating that it may be non-inducible and that it is constitutively 
expressed (Christie and Dixon, unpublished). The lack of a significant response in S25-7 
expression to rCK-2 treatment of RTS-11 provides further evidence of its constitutive nature. 
Although the co-receptor CD4 is most famously expressed on the surface of T-cells, it has 
also been found expressed in macrophages (Filion et al., 1990). In fact, human monocytes 
have also been shown to express CD4 intracellularly (Filion et al., 1990). It is interesting that 
an increase was seen in CD4 transcript level in response to rCK-2 as research groups 
studying human monocytes showed that CD4 is downregulated in response to various 
stimulants (Graziani-Bowering and Filion, 2000). Herbein et al., reported that treatment of 
human monocytes with LPS, TNFα and IL-1β all caused decreases in both cytosolic and cell 
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surface CD4 (Herbein et al., 1995). It was also seen in this study that the inhibition of CD4 
was occurring at the RNA level, indicating transcriptional regulation of CD4 expression 
(Herbein et al., 1995). This conclusion makes the observed increase in CD4 transcript in 
response to rCK-2 even more curious. In addition, Herbein et al. found that the CC 
chemokines they tested had no effect on the expression of CD4 (Herbein et al., 1995). Since 
rCK-2 was seen to cause an increase in TNFα and IL-1β, it is possible that if these pro-
inflammatory cytokines are secreted that they could act in an autocrine manner and cause a 
potential decrease in CD4 expression later on in the time course. Future studies should 
investigate whether rCK-2 is capable of inducing CD4 at the protein level and whether this 
increase as well as the increase in CD4 mRNA is reversed at a later time. 
It was concluded by Graziani-Bowering and Filion that the downregulation of monocyte cell 
surface CD4 was mostly likely caused by their differentiation into macrophages (Graziani-
Bowering and Filion, 2000). In light of this, it can be postulated that the monocyte-like cells 
in the samples were not undergoing differentiation. Nevertheless, the upregulation that was 
seen in TNFα and IL-1β could indicate that rCK-2 is initiating the differentiation of the 
monocyte-like cells into macrophage-like cells through the induction of these cytokines. In 
fact, it was concluded from the Herbein et al. study that the LPS-inhibition of CD4 was 
mediated by TNFα and IL-1β (Herbein et al., 1995). If there is a decrease in CD4 later in the 
time course, it would then be possible that rCK-2 is a trigger for CK-2 differentiation. 
However if the increase in CD4 is mirrored at the protein level and is seen to be a prolonged 
induction, it is possible that the rCK-2-induced increase in cell surface CD4 acts as a 
negative feedback mechanism to modulate the monocyte response to chemokines. CD4 is 
known to be a co-receptor for human immunodeficiency virus (HIV) in monocytes and 
macrophages, as well as T-lymphocytes. CD4 stimulation by the HIV envelope glycoprotein 
gp120 has been seen to cause internalization of chemokine receptors from monocyte cell 
surfaces (Wang et al., 1998). The downregulation in chemokine receptor expression caused 
decreased sensitivity to chemokines in monocytes (Wang et al., 1998). The RTS-11 
monocyte response to rCK-2 was to increase the expression of cytokines that trigger 
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inflammation and the T-cell mediated response. The continued secretion of molecules such 
as IL-1β, TNFα and interferons is not beneficial since they have many downstream effects in 
addition to inflammatory and T-cell responses. Consequently, it would make sense for the 
chemokine signal that triggers their production to be turned off by negative feedback. In 
addition, activated macrophages need to migrate to peripheral lymphoid tissues in order to 
trigger the adaptive immune response and does so by following a chemokine concentration 
gradient. However, if the activated macrophages are still responding to the chemokines that 
they had followed to the site of infection there would be two opposing signals pulling the 
cells in different directions. The activated macrophage must first turn off its response to the 
initial chemokines in order to follow the second chemokine gradient to the lymphoid tissues. 
Again, there must be some mechanism of downregulating the first signal. Along with causing 
increases in cytokine mediators of the immune response, rCK-2 may induce CD4 expression 
in order to decrease the number of chemokine receptors present on the cell surface so that it 
cannot continue responding to CK-2. This modulation of chemokine stimulation may 
represent a function of CD4 in monocytes/macrophages which is currently unknown. 
4.5 Concluding Remarks 
Based on the gene expression profile that was derived from the exposure of the 
monocyte/macrophage-like cell line RTS-11 to recombinantly produced CK-2, it can be 
postulated that CK-2 is a stimulator of the rainbow trout immune system. Not only does CK-
2 promote chemotaxis of leukocytes, it is also appears to be capable of triggering 
inflammatory responses. However, it seems as though the chemokine is non-specific in its 
actions since it upregulates mediators of the immune response towards both intracellular and 
extracellular pathogens. It is still possible that the upregulation is not perpetrated to the 
protein level. Therefore, future studies should look at the protein levels of the expression in 
the cytosol as well as whether the protein products are secreted or translocated to the 
membrane as expected. A longer time course should also be carried out in order to get a 
complete picture of the effects of CK-2. 
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In addition, the immune gene-related expression profile of the RTS-11 response to rCK-2 
exhibited an interesting upregulation of CD4, the function of which in 
monocytes/macrophages remains unknown. The chemokine-stimulated increase in 
expression of CD4 may suggest a negative feedback mechanism to control the response to 
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LPS Lipopolysaccharide 
MHIα Major histocompatibility  class I alpha chain 
MHIIβ Major histocompatibility class II beta chain 
MHIIα Major histocompatibility class II alpha chain 
Min Minute 
MYA Million years ago 
NBT 4-nitro blue tetrazolium chloride 
NTA Nitrilotriacetic acid 
PBL Peripheral blood leukocyte 
PBS Phosphate buffered saline 
PCR Polymerase chain reaction 
PHA Phytohemaglutinin 
PIP2 Phosphoinositol 4,5-bisphosphate 
PKC Protein kinase C 
PLC Phospholipase C 




rβ2Mf Recombinant β-2-microglobulin fragment 
rCK-2 Recombinant CK-2 
rRNA Ribosomal RNA 
SDS Sodium dodecyl sulphate 
SDS-PAGE Sodium dodecyl sulphate-polyacrylamide gel 
TAP Tapasin 
TBE Tris/Borate/EDTA Buffer 
TBO Toluidine blue O 
TBST Tris-buffered saline-Tween-20 
TEMED Tetramethylethylenediamine 
TH1 Type 1 helper T-cell 
TH2 Type 2 helper T-cell 
TNFα Tumour necrosis factor-α 






Figure B.1: RT-PCR analysis of IL-1β transcript levels in rCK-2-treated RTS-11. Total 
RNA was extracted from two sets of RTS-11 and used to synthesize cDNA through RT-PCR. 
IL-1β and 28s were amplified from this cDNA in two separate PCR reactions then run 
together on a GelRed-stained1.5% agarose gel in 0.5X TBE at 35V for 55 mins. 
Densitometry analysis was performed using ImageJ to determine band densities. The image 


















Figure B.2: RT-PCR analysis of TNFα transcript levels in rCK-2-treated RTS-11. Total 
RNA was extracted from two sets of RTS-11 and used to synthesize cDNA through RT-PCR. 
TNFα and 28s were amplified from this cDNA in two separate PCR reactions then run 
together on a GelRed-stained1.5% agarose gel in 0.5X TBE at 35V for 55 mins. 
Densitometry analysis was performed using ImageJ to determine band densities. The image 






















Figure B.3: RT-PCR analysis of IL-8 transcript levels in rCK-2-treated RTS-11. Total 
RNA was extracted from two sets of RTS-11 and used to synthesize cDNA through RT-PCR. 
IL-8 and 28s were amplified from this cDNA in two separate PCR reactions then run 
together on a GelRed-stained1.5% agarose gel in 0.5X TBE at 35V for 55 mins. 
Densitometry analysis was performed using ImageJ to determine band densities. The image 






















Figure B.4: RT-PCR analysis of MHIα transcript levels in rCK-2-treated RTS-11. Total 
RNA was extracted from two sets of RTS-11 and used to synthesize cDNA through RT-PCR. 
MHIα and 28s were amplified from this cDNA in two separate PCR reactions then run 
together on a GelRed-stained1.5% agarose gel in 0.5X TBE at 35V for 55 mins. 
Densitometry analysis was performed using ImageJ to determine band densities. The image 






















Figure B.5: RT-PCR analysis of IFN1 transcript levels in rCK-2-treated RTS-11. Total 
RNA was extracted from two sets of RTS-11 and used to synthesize cDNA through RT-PCR. 
IFN1 and 28s were amplified from this cDNA in two separate PCR reactions then run 
together on a GelRed-stained1.5% agarose gel in 0.5X TBE at 35V for 55 mins. 
Densitometry analysis was performed using ImageJ to determine band densities. The image 






















Figure B.6: RT-PCR analysis of IFN2 transcript levels in rCK-2-treated RTS-11. Total 
RNA was extracted from two sets of RTS-11 and used to synthesize cDNA through RT-PCR. 
IFN2 and 28s were amplified from this cDNA in two separate PCR reactions then run 
together on a GelRed-stained1.5% agarose gel in 0.5X TBE at 35V for 55 mins. 
Densitometry analysis was performed using ImageJ to determine band densities. The image 






















Figure B.7: RT-PCR analysis of MHIIα transcript levels in rCK-2-treated RTS-11. 
Total RNA was extracted from two sets of RTS-11 and used to synthesize cDNA through 
RT-PCR. MHIIα and 28s were amplified from this cDNA in two separate PCR reactions then 
run together on a GelRed-stained1.5% agarose gel in 0.5X TBE at 35V for 55 mins. 
Densitometry analysis was performed using ImageJ to determine band densities. The image 






















Figure B.8: RT-PCR analysis of S25-7 transcript levels in rCK-2-treated RTS-11. Total 
RNA was extracted from two sets of RTS-11 and used to synthesize cDNA through RT-PCR. 
S25-7 and 28s were amplified from this cDNA in two separate PCR reactions then run 
together on a GelRed-stained1.5% agarose gel in 0.5X TBE at 35V for 55 mins. 
Densitometry analysis was performed using ImageJ to determine band densities. The image 























Figure B.9: RT-PCR analysis of CD4 transcript levels in rCK-2-treated RTS-11. Total 
RNA was extracted from two sets of RTS-11 and used to synthesize cDNA through RT-PCR. 
CD4 and 28s were amplified from this cDNA in two separate PCR reactions then run 
together on a GelRed-stained1.5% agarose gel in 0.5X TBE at 35V for 55 mins. 
Densitometry analysis was performed using ImageJ to determine band densities. The image 























Table C.1: Cell counts of the migration towards each treatment in the chemotaxis assay. 
Three fields of view were counted in each well and are averaged here. Three wells were used 
for each treatment. The chemotactic index represents the ratio of the number of cells that 
migrated towards the substance of interest to the number of cells that migrated towards the 
negative control, PBS. 
(A) Chemotaxis assay using RTS-11 cells to test the chemotactic ability of CK-2. The 





Well 1 Well 2 Well 3 Average Std. Dev. 
Chemotactic 
Index 
PBS  0 0 82.67 27.56 41.5 1.00 
β2Mf 
1000 0 0 84.3 28.11 42.3 1.02 
500 0 0 0 0 0 0 
100 0 128.3 0 42.8 64.6 1.55 
50 127 134 101.3 120.78 27.2 4.38 
CK-2 
1000 173.3 185.7 178 179 22.2 6.49 
500 167 195 229 197 31.1 7.15 
100 228.2 236.2 191.7 215.4 20.6 7.82 
50 173 210 175.7 186.2 36.1 6.76 









(B) Chemotaxis assay using PBLs to test the chemotactic ability of CK-2.  
 Dose 
(ng/mL) 
Well 1 Well 2 Well 3 Average Std. Dev. 
Chemotactic 
Index 
PBS  61 0.7 19.7 27.1 30.9 1 
β2Mf 
1000 10.7 8.3 6.7 8.6 2 0.32 
500 30.7 59.3 51 47 14.8 1.73 
100 33.3 79 61.3 57.9 23 2.14 
50 67.3 27.3 33.7 42.8 21.5 1.58 
CK-2 
1000 53 24 52.3 43.11 16.6 1.59 
500 139 94.7 61.7 98.4 38.8 3.63 
100 94.7 139.7 151.7 128.7 30.1 4.75 
50 71.7 74 111.3 85.7 22.3 3.16 
C5a  81.3 108.3 138 109.2 28.3 4.03 
 
(C)      Chemotaxis assay using RTS-11 blocked with PTX. 
 
Well 1 Well 2 Well 3 Average Std. Dev. 
Chemotactic 
Index 
PBS 58.7 55.3 13.7 42.6 25.1 1 
β2Mf 69 74.7 18.7 54.1 30.8 1.27 
CK-2 96.7 98.3 114 103 9.6 2.42 
PTX-CK-2 55 73.3 76 68.1 11.4 1.6 











(D)  Chemotaxis assay using PBLs blocked with PTX 
 
 
Well 1 Well 2 Well 3 Average Std. Dev. 
Chemotactic 
Index 
PBS 6 23 24.7 17.9 10.3 1 
β2Mf 143 122.7 87.3 117.7 28.2 6.62 
CK-2 189.3 180.3 170 179.8 9.9 10.05 
PTX-CK-2 78 92.3 122.3 97.6 22.6 5.45 
























Table C.2: Densitometry analysis of RT-PCR of IL-1β mRNA in RTS-11 treated with 
rCK-2. Values are corrected for the expression of the internal control gene, 28s. The average 





Trial 1 Trial 2 
Average St. Dev. 
IL-1β 28s IL-1β/28s IL-1β 28s IL-1β/28s 
0 6.53 7.63 0.86 6.03 6.04 1.00 0.93 0.10 
30 6.59 9.41 0.70 5.59 6.73 0.83 0.77 0.09 
60 5.04 5.95 0.85 5.55 6.63 0.84 0.84 0.01 
75 5.32 6.06 0.88 5.19 8.37 0.62 0.75 0.18 
90 7.32 7.09 1.03 5.59 5.86 0.95 0.99 0.06 
105 5.60 4.73 1.18 5.39 6.57 0.82 1.00 0.26 
120 6.77 4.83 1.40 5.90 7.69 0.77 1.08 0.45 
150 6.10 6.07 1.01 6.25 5.69 1.10 1.05 0.07 
180 7.03 4.81 1.46 5.52 6.76 0.82 1.14 0.46 
240 6.43 4.78 1.34 7.06 5.63 1.25 1.30 0.06 
Dose (ng/mL)                 
0 6.46 3.96 1.63 6.20 5.84 1.06 1.35 0.40 
5 6.34 7.77 0.82 6.43 5.23 1.23 1.02 0.29 
10 5.22 6.58 0.79 6.44 4.71 1.37 1.08 0.41 
50 6.29 7.37 0.85 5.89 5.17 1.14 1.00 0.20 
100 6.11 5.96 1.02 5.68 4.56 1.25 1.14 0.16 
500 0.13 3.22 0.04 5.57 4.97 1.12 0.58 0.76 












Table C.3: Densitometry analysis of RT-PCR of TNFα mRNA in RTS-11 treated with 
rCK-2. Values are corrected for the expression of the internal control gene, 28s. The average 





Trial 1 Trial 2 
Average St. Dev. 
TNFα 28s TNFα/28s TNFα 28s TNFα/28s 
0 5.34 6.40 0.83 5.30 5.88 0.90 0.87 0.05 
30 6.88 7.37 0.93 4.28 5.16 0.83 0.88 0.07 
60 5.10 5.91 0.86 6.77 6.26 1.08 0.97 0.15 
75 5.77 6.96 0.83 6.32 6.34 1.00 0.91 0.12 
90 5.64 5.91 0.95 6.62 6.21 1.06 1.01 0.08 
105 6.69 4.72 1.42 5.82 5.94 0.98 1.20 0.31 
120 5.25 4.12 1.27 5.59 5.63 0.99 1.13 0.20 
150 6.46 6.03 1.07 5.06 5.11 0.99 1.03 0.06 
180 6.72 5.03 1.34 5.59 5.76 0.97 1.15 0.26 
240 7.09 5.81 1.22 6.85 5.70 1.20 1.21 0.01 
Dose 
(ng/mL)                 
0 3.66 5.28 0.69 5.68 5.60 1.01 0.85 0.23 
5 7.18 7.13 1.01 5.15 5.59 0.92 0.96 0.06 
10 6.66 6.62 1.01 5.30 4.85 1.09 1.05 0.06 
50 7.56 7.90 0.96 5.62 5.26 1.07 1.01 0.08 
100 6.11 6.62 0.92 5.76 5.42 1.06 0.99 0.10 
500 2.34 3.38 0.69 4.97 4.90 1.01 0.85 0.23 












Table C.4: Densitometry analysis of RT-PCR of IL-8 mRNA in RTS-11 treated with 
rCK-2. Values are corrected for the expression of the internal control gene, 28s. The average 




Trial 1 Trial 2 
Average St. Dev. 
IL-8 28s IL-8/28s IL-8 28s IL-8/28s 
0 6.29 6.80 0.93 6.69 6.48 1.03 0.98 0.08 
30 6.16 8.48 0.73 7.29 5.26 1.39 1.06 0.47 
60 6.46 7.99 0.81 4.12 6.56 0.63 0.72 0.13 
75 6.34 5.89 1.08 6.68 7.22 0.93 1.00 0.11 
90 6.63 5.85 1.13 3.48 7.00 0.50 0.82 0.45 
105 5.86 7.14 0.82 6.62 6.60 1.00 0.91 0.13 
120 4.81 3.43 1.40 6.22 6.44 0.97 1.19 0.31 
150 6.99 5.14 1.36 7.26 6.33 1.15 1.25 0.15 
180 5.02 4.71 1.07 7.67 6.13 1.25 1.16 0.13 
240 7.10 5.63 1.26 5.21 6.16 0.85 1.05 0.29 
Dose 
(ng/mL)                 
0 6.88 4.46 1.54 6.24 5.14 1.22 1.38 0.23 
5 3.35 7.41 0.45 5.17 4.71 1.10 0.77 0.46 
10 6.61 5.37 1.23 4.93 4.40 1.12 1.18 0.08 
50 6.82 7.54 0.90 4.11 4.61 0.89 0.90 0.01 
100 6.30 6.38 0.99 2.95 4.41 0.67 0.83 0.23 
500 4.47 3.54 1.26 2.97 4.17 0.71 0.99 0.39 













Table C.5: Densitometry analysis of RT-PCR of MHIα mRNA in RTS-11 treated with 
rCK-2. Values are corrected for the expression of the internal control gene, 28s. The average 





Trial 1 Trial 2 
Average St. Dev. 
MHIα 28s MHIα/28s MHIα 28s MHIα/28s 
0 5.94 8.41 0.71 5.58 4.78 1.17 0.94 0.33 
30 6.04 10.36 0.58 6.09 6.50 0.94 0.76 0.25 
60 6.17 6.39 0.96 4.67 6.64 0.70 0.83 0.18 
75 6.08 6.61 0.92 5.76 7.77 0.74 0.83 0.13 
90 6.34 7.97 0.79 4.79 6.01 0.80 0.80 0.00 
105 6.51 4.90 1.33 5.57 6.37 0.87 1.10 0.32 
120 6.04 5.08 1.19 6.25 7.06 0.89 1.04 0.21 
150 6.66 6.68 1.00 5.87 6.55 0.90 0.95 0.07 
180 6.51 5.32 1.22 6.40 5.42 1.18 1.20 0.03 
240 5.90 4.88 1.21 6.17 8.07 0.76 0.99 0.31 
Dose 
(ng/mL)                 
0 6.27 4.15 1.51 6.21 6.12 1.02 1.26 0.35 
5 5.42 9.06 0.60 6.13 4.96 1.24 0.92 0.45 
10 5.68 5.35 1.06 5.76 4.26 1.35 1.21 0.21 
50 5.41 6.39 0.85 6.28 4.90 1.28 1.06 0.31 
100 4.78 3.89 1.23 6.49 6.44 1.01 1.12 0.16 
500 5.47 2.06 2.66 6.12 4.15 1.48 2.07 0.83 












Table C.6: Densitometry analysis of RT-PCR of IFN1 mRNA in RTS-11 treated with 
rCK-2. Values are corrected for the expression of the internal control gene, 28s. The average 





Trial 1 Trial 2 
Average St. Dev. 
IFN1 28s IFN1/28s IFN1 28s IFN1/28s 
0 6.53 7.71 0.85 5.943 7.71 0.77 0.81 0.05 
30 5.93 8.57 0.69 6.354 8.57 0.74 0.72 0.03 
60 5.43 6.30 0.86 6.004 6.30 0.95 0.91 0.06 
75 5.27 5.77 0.91 5.58 5.77 0.97 0.94 0.04 
90 6.41 6.38 1.01 4.538 6.38 0.71 0.86 0.21 
105 6.03 4.62 1.30 4.891 4.62 1.06 1.18 0.17 
120 6.69 4.92 1.36 4.119 4.92 0.84 1.10 0.37 
150 5.72 6.23 0.92 5.085 6.23 0.82 0.87 0.07 
180 6.58 5.12 1.29 6.336 5.12 1.24 1.26 0.03 
240 5.97 5.10 1.17 6.292 5.10 1.23 1.20 0.04 
Dose 
(ng/mL)                 
0 5.53 4.52 1.22 6.848 4.52 1.52 1.37 0.21 
5 6.37 7.34 0.87 5.386 7.34 0.73 0.80 0.09 
10 6.40 6.74 0.95 6.502 6.74 0.96 0.96 0.01 
50 6.70 6.97 0.96 7.15 6.97 1.03 0.99 0.05 
100 6.77 5.66 1.20 6.079 5.66 1.07 1.14 0.09 
500 1.04 3.65 0.29 6.659 3.65 1.83 1.06 1.09 












Table C.7: Densitometry analysis of RT-PCR of IFN2 mRNA in RTS-11 treated with 
rCK-2. Values are corrected for the expression of the internal control gene, 28s. The average 





Trial 1 Trial 2 
Average St. Dev. 
IFN2 28s IFN2/28s IFN2 28s IFN2/28s 
0 5.34 7.46 0.71 4.382 5.68 0.77 0.74 0.04 
30 6.88 8.22 0.84 4.684 5.79 0.81 0.82 0.02 
60 5.10 7.01 0.73 5.964 6.16 0.97 0.85 0.17 
75 5.77 6.53 0.88 6.382 6.18 1.03 0.96 0.11 
90 5.64 5.62 1.00 6.31 6.20 1.02 1.01 0.01 
105 6.69 5.84 1.15 6.682 6.33 1.06 1.10 0.06 
120 5.25 4.62 1.14 7.097 5.48 1.29 1.22 0.11 
150 6.46 6.07 1.06 6.561 5.68 1.15 1.11 0.06 
180 6.72 5.48 1.23 6.756 6.00 1.13 1.18 0.07 
240 7.09 5.73 1.24 5.066 6.05 0.84 1.04 0.28 
Dose 
(ng/mL)                 
0 5.56 4.81 1.16 6.747 6.01 1.12 1.14 0.02 
5 6.37 6.15 1.04 6.442 5.58 1.15 1.10 0.08 
10 6.25 5.71 1.09 4.667 5.01 0.93 1.01 0.11 
50 6.50 6.74 0.96 4.203 5.15 0.82 0.89 0.10 
100 5.32 5.64 0.94 4.883 5.10 0.96 0.95 0.01 
500 4.79 3.93 1.22 4.606 4.80 0.96 1.09 0.18 











Table C.8: Densitometry analysis of RT-PCR of MHIIα mRNA in RTS-11 treated with 
rCK-2. Values are corrected for the expression of the internal control gene, 28s. The average 





Trial 1 Trial 2 
Average St. Dev. 
MHIIα 28s MHIIα/28s MHIIα 28s MHIIα/28s 
0 5.66 6.39 0.89 5.66 6.63 0.85 0.87 0.02 
30 5.32 7.20 0.74 5.32 6.24 0.85 0.80 0.08 
60 5.84 5.99 0.97 5.84 6.83 0.86 0.92 0.08 
75 4.75 6.93 0.69 4.75 7.02 0.68 0.68 0.01 
90 6.56 5.94 1.10 6.56 5.83 1.13 1.11 0.01 
105 6.12 5.43 1.13 6.12 6.00 1.02 1.07 0.07 
120 5.87 4.64 1.27 5.87 5.10 1.15 1.21 0.08 
150 6.19 5.63 1.10 6.19 5.97 1.04 1.07 0.04 
180 6.27 5.09 1.23 6.27 5.11 1.23 1.23 0.00 
240 6.05 5.65 1.07 6.05 6.07 1.00 1.03 0.05 
Dose 
(ng/mL)                 
0 5.80 5.27 1.10 5.61 5.10 1.10 1.10 0.00 
5 6.06 5.99 1.01 5.97 5.45 1.10 1.05 0.06 
10 5.77 6.17 0.94 5.94 4.67 1.27 1.10 0.24 
50 6.23 7.75 0.80 5.83 5.17 1.13 0.97 0.23 
100 6.26 6.37 0.98 5.29 4.60 1.15 1.07 0.12 
500 5.39 4.22 1.28 5.36 4.45 1.20 1.24 0.05 












Table C.9: Densitometry analysis of RT-PCR of S25-7 mRNA in RTS-11 treated with 
rCK-2. Values are corrected for the expression of the internal control gene, 28s. The average 





Trial 1 Trial 2 
Average St. Dev. 
S25-7 28s S25-7/28s S25-7 28s S25-7/28s 
0 5.53 5.17 1.07 5.64 3.80 1.48 1.28 0.29 
30 6.41 8.23 0.78 4.74 5.00 0.95 0.86 0.12 
60 5.75 6.73 0.85 5.73 5.64 1.02 0.94 0.11 
75 6.08 8.42 0.72 6.32 7.86 0.80 0.76 0.06 
90 6.79 7.50 0.90 5.11 6.48 0.79 0.85 0.08 
105 5.66 5.34 1.06 4.75 6.68 0.71 0.89 0.25 
120 5.39 5.07 1.06 6.08 6.39 0.95 1.01 0.08 
150 4.73 5.85 0.81 5.70 6.17 0.92 0.87 0.08 
180 6.67 5.01 1.33 6.18 5.78 1.07 1.20 0.18 
240 7.01 5.96 1.17 6.59 6.61 1.00 1.09 0.13 
Dose 
(ng/mL)                 
0 6.59 4.83 1.36 5.70 5.20 1.10 1.23 0.19 
5 6.29 5.37 1.17 3.68 5.30 0.69 0.93 0.34 
10 6.60 6.08 1.09 6.26 3.56 1.76 1.42 0.48 
50 6.66 8.09 0.82 5.60 4.87 1.15 0.99 0.23 
100 6.51 4.54 1.43 7.04 5.29 1.33 1.38 0.07 
500 0.87 3.17 0.27 5.44 5.04 1.08 0.68 0.57 












Table C.10: Densitometry analysis of RT-PCR of CD4 mRNA in RTS-11 treated with 
rCK-2. Values are corrected for the expression of the internal control gene, 28s. The average 





Trial 1 Trial 2 
Average St. Dev. 
CD4 28s CD4/28s CD4 28s CD4/28s 
0 5.84 7.72 0.76 4.40 5.73 0.77 0.76 0.01 
30 6.33 7.27 0.87 5.07 5.07 1.00 0.93 0.09 
60 5.59 6.82 0.82 5.66 7.33 0.77 0.80 0.03 
75 5.60 6.92 0.81 5.95 7.03 0.85 0.83 0.03 
90 5.27 5.82 0.90 6.84 6.97 0.98 0.94 0.05 
105 5.49 5.76 0.95 7.20 6.89 1.05 1.00 0.07 
120 4.66 3.67 1.27 6.60 6.38 1.03 1.15 0.17 
150 5.09 5.53 0.92 5.85 6.42 0.91 0.92 0.01 
180 6.03 4.39 1.37 6.54 6.88 0.95 1.16 0.30 
240 6.61 5.57 1.19 6.58 6.58 1.00 1.09 0.13 
Dose 
(ng/mL)                 
0 5.63 4.64 1.21 6.07 5.62 1.08 1.15 0.09 
5 7.90 7.10 1.11 5.41 5.03 1.08 1.09 0.03 
10 6.89 6.14 1.12 5.14 4.18 1.23 1.18 0.08 
50 8.05 8.43 0.96 4.38 4.43 0.99 0.97 0.02 
100 5.79 6.34 0.91 4.52 4.89 0.93 0.92 0.01 
500 4.56 3.57 1.28 4.98 3.76 1.33 1.30 0.03 






Agarwal S, Piesco NP, Johns LP, Riccelli AE. 1995. Differential expression of IL-1 beta, 
TNF-alpha, IL-6, and IL-8 in human monocytes in response to lipopolysaccharides from 
different microbes. J Dent Res 74(4):1057-65. 
Auffray C, Sieweke MH, Geissmann F. 2009. Blood monocytes: Development, 
heterogeneity, and relationship with dendritic cells. Annu Rev Immunol 27:669-92. 
Baggiolini M, Dewald B, Moser B. 1997. Human chemokines: An update. Annu Rev 
Immunol 15:675-705. 
Baggiolini M, Walz A, Kunkel SL. 1989. Neutrophil-activating peptide-1/interleukin 8, a 
novel cytokine that activates neutrophils. J Clin Invest 84(4):1045-9. 
Bazan JF, Bacon KB, Hardiman G, Wang W, Soo K, Rossi D, Greaves DR, Zlotnik A, Schall 
TJ. 1997. A new class of membrane-bound chemokine with a CX3C motif. Nature 
385(6617):640-4. 
Bokoch GM. 1995. Chemoattractant signaling and leukocyte activation. Blood 86(5):1649-
60. 
Brubacher JL, Secombes CJ, Zou J, Bols NC. 2000. Constitutive and LPS-induced gene 
expression in a macrophage-like cell line from the rainbow trout (Oncorhynchus 
mykiss). Developmental & Comparative Immunology 24(6-7):565-74. 
Christie D and Dixon B. Unpublished. Regulation of MH class II associated invariant chain 
in Oncorhynchus mykiss. . 
Collet B, Munro ES, Gahlawat S, Acosta F, Garcia J, Roemelt C, Zou J, Secombes CJ, Ellis 
AE. 2007. Infectious pancreatic necrosis virus suppresses type I interferon signalling in 
rainbow trout gonad cell line but not in Atlantic salmon macrophages. Fish Shellfish 
Immunol 22(1-2):44-56. 
De Maeyer E and De Maeyer-Guignard J. 1988. Interferons and other regulatory cytokines. 
New York: John Wiley & Sons. 
Denz CR and Dube DK. 2005. The benefits of 28S rRNA for standardization of reverse 
transcription-polymerase chain reaction for studying gene expression. Anal Biochem 
341(2):382-4. 
DeVries ME, Kelvin AA, Xu L, Ran L, Robinson J, Kelvin DJ. 2006. Defining the origins 
and evolution of the chemokine/chemokine receptor system. J Immunol 176(1):401-15. 
Di Marzio P, Puddu P, Conti L, Belardelli F, Gessani S. 1994. Interferon gamma upregulates 
its own gene expression in mouse peritoneal macrophages. J Exp Med 179(5):1731-6. 
Dixon B, Shum B, Adams EJ, Magor KE, Hedrick RP, Muir DG, Parham P. 1998. CK-1, a 
putative chemokine of rainbow trout (Oncorhynchus mykiss). Immunol Rev 166:341-8. 
 
 106 
Doitsidou M, Reichman-Fried M, Stebler J, Koprunner M, Dorries J, Meyer D, Esguerra CV, 
Leung T, Raz E. 2002. Guidance of primordial germ cell migration by the chemokine 
SDF-1. Cell 111(5):647-59. 
Durig J, Testa NG, Heyworth CM. 1999. Distinct biological effects of macrophage 
inflammatory protein-1alpha and stroma-derived factor-1alpha on CD34+ hemopoietic 
cells. Stem Cells 17(2):62-71. 
Eshaque S, Fujiki K, Mitchell L, Bols N, Dixon B. Unpublished. Functional characterization 
of the rainbow trout (Oncorhynchus mykiss) chemokine 2 (CK-2) gene. . 
Fantuzzi L, Belardelli F, Gessani S. 2003. Monocyte/macrophage-derived CC chemokines 
and their modulation by HIV-1 and cytokines: A complex network of interactions 
influencing viral replication and AIDS pathogenesis. J Leukoc Biol 74(5):719-25. 
Filion LG, Izaguirre CA, Garber GE, Huebsh L, Aye MT. 1990. Detection of surface and 
cytoplasmic CD4 on blood monocytes from normal and HIV-1 infected individuals. J 
Immunol Methods 135(1-2):59-69. 
Fultz MJ, Barber SA, Dieffenbach CW, Vogel SN. 1993. Induction of IFN-gamma in 
macrophages by lipopolysaccharide. Int Immunol 5(11):1383-92. 
Gessani S, Testa U, Varano B, Di Marzio P, Borghi P, Conti L, Barberi T, Tritarelli E, 
Martucci R, Seripa D. 1993. Enhanced production of LPS-induced cytokines during 
differentiation of human monocytes to macrophages. role of LPS receptors. Journal of 
Immunology 151(7):3758-66. 
Glimcher LH and Kara CJ. 1992. Sequences and factors: A guide to MHC class-II 
transcription. Annu Rev Immunol 10:13-49. 
Godiska R, Chantry D, Raport CJ, Sozzani S, Allavena P, Leviten D, Mantovani A, Gray 
PW. 1997. Human macrophage-derived chemokine (MDC), a novel chemoattractant for 
monocytes, monocyte-derived dendritic cells, and natural killer cells. J Exp Med 
185(9):1595-604. 
Graves DT and Jiang Y. 1995. Chemokines, a family of chemotactic cytokines. Crit Rev Oral 
Biol Med 6(2):109-18. 
Graziani-Bowering GM and Filion LG. 2000. Down regulation of CD4 expression following 
isolation and culture of human monocytes. Clinical & Diagnostic Laboratory 
Immunology 7(2):182-91. 
Gu L, Tseng S, Horner RM, Tam C, Loda M, Rollins BJ. 2000. Control of TH2 polarization 
by the chemokine monocyte chemoattractant protein-1. Nature 404(6776):407-11. 
Hansen JD and La Patra S. 2002. Induction of the rainbow trout MHC class I pathway during 





Herbein G, Doyle AG, Montaner LJ, Gordon S. 1995. Lipopolysaccharide (LPS) down-
regulates CD4 expression in primary human macrophages through induction of 
endogenous tumour necrosis factor (TNF) and IL-1 beta. Clinical & Experimental 
Immunology 102(2):430-7. 
Jasinski M, Wieckiewicz J, Ruggiero I, Pituch-Noworolska A, Zembala M. 1995. Isotype-
specific regulation of MHC class II gene expression in human monocytes by exogenous 
and endogenous tumor necrosis factor. J Clin Immunol 15(4):185-93. 
Jiang Y, Beller DI, Frendl G, Graves DT. 1992. Monocyte chemoattractant protein-1 
regulates adhesion molecule expression and cytokine production in human monocytes. 
Journal of Immunology 148(8):2423-8. 
Jorgensen SM, Syvertsen BL, Lukacs M, Grimholt U, Gjoen T. 2006. Expression of MHC 
class I pathway genes in response to infectious salmon anaemia virus in atlantic salmon 
(Salmo salar L.) cells. Fish Shellfish Immunol 21(5):548-60. 
Karpus WJ, Lukacs NW, Kennedy KJ, Smith WS, Hurst SD, Barrett TA. 1997. Differential 
CC chemokine-induced enhancement of T helper cell cytokine production. Journal of 
Immunology 158(9):4129-36. 
Kelner GS, Kennedy J, Bacon KB, Kleyensteuber S, Largaespada DA, Jenkins NA, 
Copeland NG, Bazan JF, Moore KW, Schall TJ. 1994. Lymphotactin: A cytokine that 
represents a new class of chemokine. Science 266(5189):1395-9. 
Kelvin DJ, Michiel DF, Johnston JA, Lloyd AR, Sprenger H, Oppenheim JJ, Wang JM. 
1993. Chemokines and serpentines: The molecular biology of chemokine receptors. J 
Leukoc Biol 54(6):604-12. 
Khattiya R, Ohira T, Hirono I, Aoki T. 2004. Identification of a novel japanese flounder 
(Paralichthys olivaceus) CC chemokine gene and an analysis of its function. 
Immunogenetics 55(11):763-9. 
Kileng O, Brundtland MI, Robertsen B. 2007. Infectious salmon anemia virus is a powerful 
inducer of key genes of the type I interferon system of atlantic salmon, but is not 
inhibited by interferon. Fish Shellfish Immunol 23(2):378-89. 
Kim IS, Jang SW, Sung HJ, Lee JS, Ko J. 2005. Differential CCR1-mediated chemotaxis 
signaling induced by human CC chemokine HCC-4/CCL16 in HOS cells. FEBS Lett 
579(27):6044-8. 
Knight I, Stet RJM, Secombes CJ. 1998. Modulation of MHC class II expression in rainbow 
trout (Oncorhynchus mykiss) macrophages by TNFα and LPS, Fish Shellfish Immunol 
8(7):545-53. 
Koppang EO, Dannevig BH, Lie Ø, RØnningen K, Press CM. 1999. Expression of mhc class 
I and II mRNA in a macrophage-like cell line (SHK-1) derived from atlantic salmon, 
salmo salar L., head kidney. Fish Shellfish Immunol 9(6):473-89. 
Laing KJ and Secombes CJ. 2004. Chemokines. Dev Comp Immunol 28(5):443-60. 
 
 108 
Laing KJ and Secombes CJ. 2004. Trout CC chemokines: Comparison of their sequences and 
expression patterns. Mol Immunol 41(8):793-808. 
Laing KJ, Zou JJ, Wang T, Bols N, Hirono I, Aoki T, Secombes CJ. 2002. Identification and 
analysis of an interleukin 8-like molecule in rainbow trout (Oncorhynchus mykiss). Dev 
Comp Immunol 26(5):433-44. 
Laing KJ, Wang T, Zou J, Holland J, Hong S, Bols N, Hirono I, Aoki T, Secombes CJ. 2001. 
Cloning and expression analysis of rainbow trout (Oncorhynchus mykiss) tumour 
necrosis factor-alpha. European Journal of Biochemistry 268(5):1315-22. 
Lally J, Al-Anouti F, Bols N, Dixon B. 2003. The functional characterisation of CK-1, a 
putative CC chemokine from rainbow trout (Oncorhynchus mykiss). Fish Shellfish 
Immunol 15(5):411-24. 
Lin G, Pearson AE, Scamurra RW, Zhou Y, Baarsch MJ, Weiss DJ, Murtaugh MP. 1994. 
Regulation of interleukin-8 expression in porcine alveolar macrophages by bacterial 
lipopolysaccharide. J Biol Chem 269(1):77-85. 
Liu L, Fujiki K, Dixon B, Sundick RS. 2002. Cloning of a novel rainbow trout 
(Oncorhynchus mykiss) CC chemokine with a fractalkine-like stalk and a TNF decoy 
receptor using cDNA fragments containing AU-rich elements. Cytokine 17(2):71-81. 
Locati M, Deuschle U, Massardi ML, Martinez FO, Sironi M, Sozzani S, Bartfai T, 
Mantovani A. 2002. Analysis of the gene expression profile activated by the CC 
chemokine ligand 5/RANTES and by lipopolysaccharide in human monocytes. Journal 
of Immunology 168(7):3557-62. 
Matsunaga T and Rahman A. 1998. What brought the adaptive immune system to 
vertebrates?--the jaw hypothesis and the seahorse. Immunol Rev 166:177-86. 
McBeath AJ, Snow M, Secombes CJ, Ellis AE, Collet B. 2007. Expression kinetics of 
interferon and interferon-induced genes in atlantic salmon (Salmo salar) following 
infection with infectious pancreatic necrosis virus and infectious salmon anaemia virus. 
Fish Shellfish Immunol 22(3):230-41. 
Melchjorsen J, Sorensen LN, Paludan SR. 2003. Expression and function of chemokines 
during viral infections: From molecular mechanisms to in vivo function. J Leukoc Biol 
74(3):331-43. 
Melchjorsen J, Sirén J, Julkunen I, Paludan SR, Matikainen S. 2006. Induction of cytokine 
expression by herpes simplex virus in human monocyte-derived macrophages and 
dendritic cells is dependent on virus replication and is counteracted by ICP27 targeting 
NF-κB and IRF-3. J Gen Virol 87(5):1099-108. 
Molyneaux KA, Zinszner H, Kunwar PS, Schaible K, Stebler J, Sunshine MJ, O'Brien W, 
Raz E, Littman D, Wylie C, et al. 2003. The chemokine SDF1/CXCL12 and its receptor 




Montero J, Chaves-Pozo E, Cuesta A, Tafalla C. 2009. Chemokine transcription in rainbow 
trout (Oncorhynchus mykiss) is differently modulated in response to viral hemorrhagic 
septicaemia virus (VHSV) or infectious pancreatic necrosis virus (IPNV). Fish Shellfish 
Immunol 27(6):661-9. 
Montero J, Coll J, Sevilla N, Cuesta A, Bols NC, Tafalla C. 2008. Interleukin 8 and CK-6 
chemokines specifically attract rainbow trout (oncorhynchus mykiss) RTS11 monocyte-
macrophage cells and have variable effects on their immune functions. Developmental 
& Comparative Immunology 32(11):1374-84. 
Murphy KM, Travers P, Walport M. 2007. Janeway's immunobiology, 7th ed. London: 
Garland Science. 
Murphy PM. 1994. The molecular biology of leukocyte chemoattractant receptors. Annu Rev 
Immunol 12:593-633. 
Najakshin AM, Mechetina LV, Alabyev BY, Taranin AV. 1999. Identification of an IL-8 
homolog in lamprey (Lampetra fluviatilis): Early evolutionary divergence of 
chemokines. Eur J Immunol 29(2):375-82. 
Nakamura H, Herzenberg LA, Bai J, Araya S, Kondo N, Nishinaka Y, Herzenberg LA, 
Yodoi J. 2001. Circulating thioredoxin suppresses lipopolysaccharide-induced 
neutrophil chemotaxis. PNAS 98(26):15143-8. 
Nelson RT, Boyd J, Gladue RP, Paradis T, Thomas R, Cunningham AC, Lira P, Brissette 
WH, Hayes L, Hames LM, et al. 2001. Genomic organization of the CC chemokine mip-
3alpha/CCL20/larc/exodus/SCYA20, showing gene structure, splice variants, and 
chromosome localization. Genomics 73(1):28-37. 
Nomiyama H, Mera A, Ohneda O, Miura R, Suda T, Yoshie O. 2001. Organization of the 
chemokine genes in the human and mouse major clusters of CC and CXC chemokines: 
Diversification between the two species. Genes Immun 2(2):110-3. 
Nomiyama H, Hieshima K, Osada N, Kato-Unoki Y, Otsuka-Ono K, Takegawa S, Izawa T, 
Yoshizawa A, Kikuchi Y, Tanase S, et al. 2008. Extensive expansion and diversification 
of the chemokine gene family in zebrafish: Identification of a novel chemokine 
subfamily CX. BMC Genomics 9:222. 
Pancer Z and Mariuzza RA. 2008. The oldest antibodies newly discovered. Nat Biotechnol 
26(4):402-3. 
Pardigol A, Forssmann U, Zucht HD, Loetscher P, Schulz-Knappe P, Baggiolini M, 
Forssmann WG, Magert HJ. 1998. HCC-2, a human chemokine: Gene structure, 
expression pattern, and biological activity. Proc Natl Acad Sci U S A 95(11):6308-13. 
Peatman E and Liu Z. 2007. Evolution of CC chemokines in teleost fish: A case study in 
gene duplication and implications for immune diversity. Immunogenetics 59(8):613-23. 
 
 110 
Puddu P, Fantuzzi L, Borghi P, Varano B, Rainaldi G, Guillemard E, Malorni W, Nicaise P, 
Wolf SF, Belardelli F, et al. 1997. IL-12 induces IFN-gamma expression and secretion 
in mouse peritoneal macrophages. Journal of Immunology 159(7):3490-7. 
Remick DG. 2005. Interleukin-8. Crit Care Med 33(12 Suppl):S466-7. 
Rolff J. 2007. Why did the acquired immune system of vertebrates evolve?. Dev Comp 
Immunol 31(5):476-82. 
Saksela E, Virtanen I, Hovi T, Secher DS, Cantell K. 1984. Monocyte is the main producer 
of human leukocyte alpha interferons following sendai virus induction. Progress in 
Medical Virology 30:78-86. 
Sambrook J, Fritsch EF, Maniatis T. 1989. Molecular cloning: A laboratory manual. Cold 
Spring Harbor, NY: Cold Spring Harbor Laboratory Press. 
Soldevila G and Garcia-Zepeda EA. 2007. The role of the jak-stat pathway in chemokine-
mediated signaling in T lymphocytes. Signal Transduction 7:427. 
Tasaki Y, Fukuda S, Iio M, Miura R, Imai T, Sugano S, Yoshie O, Hughes AL, Nomiyama 
H. 1999. Chemokine PARC gene (SCYA18) generated by fusion of two MIP-
1alpha/LD78alpha-like genes. Genomics 55(3):353-7. 
Taub DD, Turcovski-Corrales SM, Key ML, Longo DL, Murphy WJ. 1996. Chemokines and 
T lymphocyte activation: I. beta chemokines costimulate human T lymphocyte 
activation in vitro. Journal of Immunology 156(6):2095-103. 
Vila-Coro AJ, Rodriguez-Frade JM, Martin De Ana A, Moreno-Ortiz MC, Martinez-A C, 
Mellado M. 1999. The chemokine SDF-1alpha triggers CXCR4 receptor dimerization 
and activates the JAK/STAT pathway. FASEB Journal 13(13):1699-710. 
Viola A, Contento RL, Molon B. 2006. T cells and their partners: The chemokine dating 
agency. Trends Immunol 27(9):421-7. 
Volff JN. 2005. Genome evolution and biodiversity in teleost fish. Heredity 94(3):280-94. 
Wang JM, Ueda H, Howard OM, Grimm MC, Chertov O, Gong X, Gong W, Resau JH, 
Broder CC, Evans G, et al. 1998. HIV-1 envelope gp120 inhibits the monocyte response 
to chemokines through CD4 signal-dependent chemokine receptor down-regulation. 
Journal of Immunology 161(8):4309-17. 
Wareing MD, Lyon AB, Lu B, Gerard C, Sarawar SR. 2004. Chemokine expression during 
the development and resolution of a pulmonary leukocyte response to influenza A virus 
infection in mice. J Leukoc Biol 76(4):886-95. 
Yoshida T, Imai T, Takagi S, Nishimura M, Ishikawa I, Yaoi T, Yoshie O. 1996. Structure 
and expression of two highly related genes encoding SCM-1/human lymphotactin. 
FEBS Lett 395(1):82-8. 
Zapata A, Diez B, Cejalvo T, Gutierrez-de Frias C, Cortes A. 2006. Ontogeny of the immune 
system of fish. Fish Shellfish Immunol 20(2):126-36. 
 
 111 
Zlotnik A and Yoshie O. 2000. Chemokines: A new classification system and their role in 
immunity. Immunity 12(2):121-7. 
Zlotnik A, Yoshie O, Nomiyama H. 2006. The chemokine and chemokine receptor 
superfamilies and their molecular evolution. Genome Biol 7(12):243. 
Zou J, Tafalla C, Truckle J, Secombes CJ. 2007. Identification of a second group of type I 
IFNs in fish sheds light on IFN evolution in vertebrates. Journal of Immunology 
179(6):3859-71. 
Zou J, Grabowski PS, Cunningham C, Secombes CJ. 1999. Molecular cloning of interleukin 
1beta from rainbow trout (Oncorhynchus mykiss) reveals no evidence of an ice cut site. 
Cytokine 11(8):552-60. 
 
 
 
